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SUMMARY 
Recent evidence suggests that early life events have a central, life-long role in atopic 
sensitization. The effect is based on the postnatal conversion in T helper (Th) cell 
balance. During pregnancy the maternal and foetoplacental Th balance is Th2-deviated, 
after which it polarizes to the normal Th1 cell-dominant profile. Priming of the 
immunological memory is assumed to occur during this period of conversion.  
Prematurely born infants often have at birth a severely immature immune and 
intestinal system. Antigen exposure during their neonatal period also diverges markedly 
from that of infants born at term. Thus, based on the current theory of the importance of 
early life events in priming of immunological memory, the atopic predisposition of 
prematurely born children can be assumed to differ from that of an unselected 
population of children.   
The aim of this study was to evaluate the association between prematurity and 
atopy from two perspectives. In the first part of the study, the atopic status of 
prematurely born children was examined and compared with that of children born at 
term. We thus invited 100 consecutive prematurely born children with very low birth 
weight (VLBW) (birth weight ≤1500 g) to participate, selecting as controls 96 age-
matched schoolchildren (birth weight >2500 g). Of the preterm and full-term groups, 
72% and 68%, respectively, opted to participate. Both groups were examined at a mean 
age of 10.1 years at an outpatient clinic. Data on atopy were collected with a 
questionnaire, by performing skin prick testing (SPT) and by measuring serum total and 
three allergen-specific IgE antibodies. We further measured serum eosinophil cationic 
protein (ECP); serum IgG and IgA isotype antibodies to whole cow’s milk, β-
lactoglobulin, α-casein and ovalbumin; and IgG antibodies to gliadin. IgG antibody 
levels to tetanus and diphtheria toxoids were measured to estimate the general antibody 
production capacity. Data on prenatal and neonatal events affecting children in the 
preterm group were collected from hospital records.  
Results showed that prematurity was linked to a decreased long-term risk of 
atopic sensitization. By age 10 years, children born preterm had significantly less atopy 
than their full-term peers; 15% versus 31% were defined as having had obvious atopy 
(atopic symptoms in at least one organ and at least one objective finding of an atopic 
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reaction) (odds ratio (OR) 0.41, 95% confidence interval (CI) 0.18-0.93, p=0.03). The 
mean value of serum total IgE was significantly lower in the preterm group, 41 kU/l 
versus 74 kU/l (p=0.02). In SPT, the children born full-term had positive reactions two 
to three times more often; 37% versus 17% had at least one positive reaction (p=0.007).  
The difference in immune response between preterm and full-term children was 
also seen in food antigen responses. Children born preterm had markedly lower levels 
of antibodies to milk and its protein fractions (p<0.001 for IgA and IgG antibodies to 
cow’s milk and α-casein and for IgG antibodies to β-lactoglobulin).  IgG gliadin 
antibodies were also significantly lower in the preterm group (p=0.03), while for IgG 
ovalbumin antibodies the difference was not significant.  In the preterm group, both 
those born before gestational week 30 and those given milk formula early (before day 
50) had the lowest levels of milk antibodies. In the preterm group, atopy was associated 
with low levels of IgG milk antibodies but high levels of IgG ovalbumin antibodies. 
Thus, since the capacity to develop specific immunity against foreign antigens was 
shown to be compromised in preterm infants, it is likely that oral tolerance in this group 
is induced by early initiation of feeding, reflecting the effect of the immature 
gastrointestinal and immune systems. The presence of less atopy in these children is 
another marker of tolerance development. 
Children born preterm had significantly more wheezing. The cumulative 
incidence of wheezing was 43%, as compared with 17% in children born full-term (OR 
3.71, 95% CI 1.67-8.25, p=0.001). Wheezing was significantly associated with atopy in 
the full-term group but not in the preterm group (64% of full-term wheezers versus 23% 
of preterm wheezers were defined as atopic, p=0.024). In the preterm group, wheezing 
was associated with neonatal factors related to severe immaturity (low gestational age, 
respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD); p=0.039, 
p<0.001 and p<0.001, respectively). Current wheezing at the age of 10 years was, by 
contrast, no longer related to the above-mentioned neonatal variables but was instead 
associated with atopy; wheezers of the preterm group who had wheezed at age 10 were 
significantly more often atopic than those who no longer wheezed (62% vs. 9%, 
p=0.006). In spirometry testing, children born preterm exhaled significantly lower 
values of all measured variables. In the preterm group, wheezing, asthma and low 
gestational age, but not atopy, were significantly associated with lower lung function 
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values. The results show that the background of respiratory morbidity in preterm 
children differs markedly from that in an unselected population of children. 
In the second part of the study, we analysed the possible association of maternal 
atopy with preterm birth. The study consisted of an inquiry about atopic symptoms and 
doctor-diagnosed atopic diseases of parents of 370 VLBW (birth weight <1500 g) 
children and of parents of 544 children born at term (birth weight >3000 g). The 
response rate was 56% for both groups. The trend test showed that the risk of maternal 
allergic rhinitis grew in parallel with infant’s birth weight (p=0.03). The probability of 
mothers of extremely low birth weight (ELBW) infants (birth weight <1000 g) to have 
doctor-diagnosed allergic rhinitis was significantly lower (OR 0.49, 95% CI 0.26-0.89) 
than that of mothers of infants born at term. Fathers of infants of different birth weights 
showed no differences in prevalence of atopic symptoms. This finding suggests that the 
maternal atopy-related immune balance may have an effect on maintenance of 
pregnancy. 
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INTRODUCTION 
An infant is defined as premature if gestational age at birth is less than 37 weeks. The 
proportion of preterm infants of all newborns in Finland during the last decade has been 
5.4-6.3%. Very low birth weight (VLBW) infants have a birth weight of less than 1500 
g, and extremely low birth weight (ELBW) infants of less than 1000 g. VLBW infants 
constitute 15% of all infants born preterm. In 2001, altogether 55 997 babies were born 
in Finland, 3373 of whom were preterm, with 494 having VLBW (National Birth 
Register). 
During recent years the outcome of children born preterm has improved markedly. 
Of the cohort of ELBW infants born in 1996-1997 in Finland, 42% at 18 months’ age 
were classified as normally developed and 18% as severely impaired (Tommiska et al. 
2003). Thus, although a major part of even the most immature infants survive without 
impairment, severely preterm infants are still at risk for several specific impairments; 
including developmental delays, poor growth and neurosensory and cognitive 
impairments. Less is known of their status in relation to the most common diseases of 
childhood, the atopic diseases. 
IgE-mediated allergic diseases, i.e. atopic diseases (atopic eczema, allergic 
rhinitis, allergic asthma), form a common health problem among otherwise healthy 
children in many western countries. By age 14, an average of 40% of Finnish children 
have had some atopic symptoms (Pekkanen et al. 1997). The causes underlying the 
increasing prevalence of atopic diseases remain obscure. However, early childhood has 
long been thought to form a critical period for the development of immunological 
memory, because after birth the T helper (Th) cell balance converts from pregnancy-
related Th2 cell-type dominance  (Wegmann et al. 1993) to Th1 cell-type profile under 
the influence of genetic and environmental factors. This occurs in “normal” non-atopic 
infants during the first year (Prescott et al. 1999). This period of conversion is now 
assumed to form the window of opportunity for atopic sensitization. 
Early life events differ significantly between infants born preterm and those born 
at term. Severely preterm children stay in a hospital for their entire neonatal period and 
need intensive care treatment, including respiratory support, intravenous nutrition and 
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repeated antibiotic treatments for infections. Preterm infants are also exposed to dietary 
antigens earlier than full-term infants. Thus, preterm infants encounter an exceptional 
environment with an immature immune system, which may have long-term effects on 
their immune system. The specific environmental factors encountered by preterm 
infants in early life are included in those assumed to be important in development of 
atopic diseases (Strachan 1989, Holt et al. 1999).  
Here, we evaluated whether immaturity at birth and subsequent environmental 
stimuli during early life are reflected in later atopic predisposition of the child. During 
the study we found evidence of interaction between maternal atopy and preterm 
delivery, which we further evaluated. Children born preterm do not form a large 
subgroup among atopic individuals. By examining their predisposition to atopy, we can, 
however, enhance the common understanding of early immunological mechanisms 
behind sensitization. 
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REVIEW OF THE LITERATURE   
DEFINITIONS OF ATOPIC DISEASES AND NEONATAL 
CHRONIC LUNG DISEASE 
Atopic diseases consist of inflammatory diseases with organ-specific symptoms such as 
atopic dermatitis, allergic rhinitis or rhinoconjunctivitis and allergic asthma. Atopic 
eczema or atopic dermatitis is defined as a chronic, relapsing, itching, inflammatory 
skin disease with typical morphology and distribution (Hanifin and Rajka 1980, Leung 
2000). Atopic eczema manifests in 90% of subjects during the first 5 years of life and 
frequently precedes the development of allergic rhinitis or asthma (Leung 2000).  
Allergic rhinitis is a combination of one or more of the following nasal symptoms: 
sneezing, itching rhinorrhoea and nasal congestion (Skoner 2001). When rhinitis is 
accompanied by itchy and watery eyes, the term allergic rhinoconjunctivitis is used. 
Allergic rhinitis frequently precedes the development of asthma; similar pro-
inflammatory mediators, T helper (Th) 2 cell cytokines, chemokines and adhesion 
molecules are found in the nasal and bronchial epithelium of subjects with allergic 
rhinitis and those with asthma (Bousquet et al. 2001).  
Martinez and Helms (1998) describe asthma as an inflammatory airway disease, a 
heterogeneous group of wheezing conditions manifesting as recurrent, reversible 
symptoms of bronchial obstruction. The definition of the Global Initiative for Asthma 
(National Institutes of Health 1995) states that ”Asthma is a chronic inflammatory 
disorder of the airways in which many cells play a role, in particular mast cells, 
eosinophils and T lymphocytes. In susceptible individuals, this inflammation causes 
recurrent episodes of wheezing, breathlessness, chest tightness and cough, particularly 
at night and/or in the early morning. These symptoms are usually associated with 
widespread but variable airflow limitation that is at least partly reversible either 
spontaneously or with treatment. The inflammation also causes an associated increase in 
airway responsiveness to a variety of stimuli”. In the Finnish asthma programme 
(Haahtela and Laitinen 1996), asthma is defined as “an inflammatory disease of the 
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bronchi, marked by increased numbers of inflammatory cells such as mast cells and 
eosinophilic white blood cells. In asthmatic individuals, inflammation causes symptoms 
including obstruction of the bronchi of varying degrees which subsides either 
spontaneously or in response to therapy. Inflammation increases the sensitivity of the 
bronchi to many irritants.”  
Of all young children experiencing recurrent wheezing, only a minority goes on to 
develop persisting atopy-related asthma. Martinez et al. (1995) specified three types of 
wheezing in children under 6 years of age: transient early wheezing with wheezing 
before 3 years of age only, persistent wheezing with symptoms both before 3 years and 
after 3 years, and late-onset wheezing with symptoms first apperaring after 3 years. A 
considerable proportion of bronchial obstruction in infants was found to be transient 
early wheezing, commonly manifesting with viral respiratory infections. Transient early 
wheezing was associated with diminished airway function at birth, before manifestation 
of any wheezing, and was not linked to asthma or allergies later in life. By contrast, 
persistent and late-onset wheezing were found to be associated with an increased risk of 
persistent asthma and allergies (Martinez et al. 1995). The same applies to asthma in 
older children and adolescents; asthma in these groups has been demonstrated to be 
closely associated with atopic diathesis, reflected in IgE responses (Burrows et al. 1989, 
Sears et al. 1991, Peat et al. 1996). 
Neonatal chronic lung disease is defined here because in a notable portion of 
children born preterm it causes long-term pulmonary consequences, including asthma-
like symptoms. Neonatal chronic lung disease, designated first as bronchopulmonary 
dysplasia (BPD), was described by Northway et al. (1967). Later, Bancalari et al. (1979) 
defined BPD as a chronic lung disease in infants who had been mechanically ventilated, 
who had clinical signs of chronic respiratory disease, who required supplemental 
oxygen for more than 28 days and who had typical changes in chest radiograph. 
Because this definition includes a wide range of infants with varying gestational 
maturation and different outcomes, Shennan et al. (1988) created a new concept of a 
chronic lung disease (CLD), whereby an infant is considered to have CLD if continuous 
oxygen supplementation at 36 weeks´ gestational age is needed. Palta et al. (1998) 
evaluated different criteria of neonatal chronic lung disease in relation to late respiratory 
complications and concluded that radiographic evidence was more predictive of long-
term respiratory outcome than other commonly used criteria. The term CLD is currently 
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most often applied to infants who after mechanical ventilation have persistent 
radiological changes and need supplemental oxygen for more than 28 days, or to those 
who have a supplemental oxygen requirement at the age of 36 weeks’ gestation, while 
the term BPD is reserved for the most severe forms of lung damage (Bancalari 2002). 
EPIDEMIOLOGY OF ATOPIC DISEASES AND PREMATURE 
BIRTH 
Prevalence of atopic diseases in children    
The prevalence of atopic diseases has increased in affluent countries (von Mutius 1998). 
In a worldwide study of prevalence of allergic diseases in children carried out in the 
1990s, the differences were found to be 20- to 60-fold between countries of the highest 
and lowest prevalence (ISAAC Steering Committee 1998). 
In Finland, four centres participated in the ISAAC study, and altogether 11 607 
children aged 13-14 years were included. The study reported prevalences of asthma 
symptoms and asthma as follows (figures varying according to the geographic region): 
wheezing ever 27-33%, wheezing in past year 13-20%, asthma ever 4-8% and doctor-
diagnosed asthma ever 4-7% (Pekkanen et al. 1997). The prevalence of allergic 
rhinoconjunctivitis and atopic eczema were as follows: rhinitis ever 44-55%, rhinitis in 
past year 33-46%, rhinoconjunctivitis in past year 15-23%, itching dermatitis 24-28%, 
eczema ever 23-26% and itching dermatitis in past year 17-22% (Remes et al. 1998). 
The cumulative incidence of atopy (atopy defined as a child ever having had atopic 
eczema or allergic rhinoconjunctivitis) was recorded to be 38-46% (Pekkanen et al. 
1997). The highest frequencies were generally recorded in the Helsinki region. 
Compared with international figures, the 12-month prevalence of asthma in Finland was 
lower than in many other affluent countries, whereas the prevalences of allergic 
rhinoconjunctivitis and atopic eczema were among the highest in the world (ISAAC 
Steering Committee 1998). 
Previous Finnish studies have reported a lower prevalence of allergic diseases in 
children and adolescents than that in the ISAAC study. Varjonen et al. (1992) carried 
out a study in 1989-1990 in the south-western part of Finland that evaluated frequencies 
of atopic diseases in 1712 adolescents aged 15-16 years. They reported the prevalence 
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of diagnosed asthma to be 2.5%, and prevalence of history of allergic rhinitis and atopic 
eczema to be 14% and 9.7%, respectively. In a multicentre study carried out in 1980 
(3649 children aged 3-18 years), the prevalence of doctor-diagnosed asthma, allergic 
rhinitis and atopic eczema were 4.3%, 6.3% and 1.7%, respectively (Pöysä et al. 1991). 
These lower figures, compared with the results of the Finnish portion of the ISAAC 
study, are partly explained by different inclusion criteria; the figures included only 
doctor-diagnosed diseases.  
Frequencies of food allergy have been difficult to determine because parents 
commonly report a range of symptoms as allergic. In a Norwegian study evaluating 
parentally perceived adverse reactions to food, the cumulative incidence of all reactions 
was 35% by age 2, and the cumulative incidence of reported adverse reactions to milk 
was 11.6% (Eggesbo et al. 1999), whereas cow’s milk allergy diagnosed by a challenge 
test has only been found in about 2% of infants (Host and Halken 1990, Saarinen et al. 
1999). 
Different atopic symptoms frequently overlap. Varjonen et al. (1992) found that 
55% of eczema patients concomitantly had allergic rhinitis and 7.8% had asthma; and 
38% of children with rhinitis and 31% of children with asthma also suffered from atopic 
eczema. Another common feature of atopic diseases is a characteristic history in the 
onset of symptoms, referred to as an “atopic/allergic march”. Atopic morbidity typically 
begins with atopic eczema and food allergies in infancy, followed by inhalant allergen 
sensitization, asthma and allergic rhinitis in later childhood (Kulig et al. 1999a, Rhodes 
et al. 2002). 
Factors contributing to atopic sensitization  
Atopic diseases are multifactorial illnesses determined by an interaction between 
genetic and environmental factors (Dold et al. 1992). Immaturity at birth may modify 
the effects of these factors by laying out a different immunological basis for postnatal 
development. The role of immaturity in atopic sensitization is reviewed in more detail 
in the section entitled “Atopy in prematurely born children”.  
During recent years the role of foetal growth in atopic diseases has been widely 
evaluated, inspired by the programming hypothesis of Barker (1998) (Godfrey et al. 
1994, Fergusson et al. 1997, Gregory et al. 1999, Leadbitter et al. 1999, Shaheen et al. 
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1999, Katz et al. 2003). The theory states that foetal events lead to permanent effects on 
the structure and function of different organs, including among others, the immune 
system. The role of foetal disproportioned growth in subsequent development of atopic 
diseases remains, however, unestablished. 
Genetic factors  
Atopic diseases have a clear genetic basis . Family history is the most important risk 
factor for atopy (Tariq et al. 1998), but even its predictive capacity has proven to be low 
(Bergmann et al. 1997). The first molecular genetic studies have examined linkage 
between atopy and human leucocyte antigen (HLA) loci. Later, by candidate gene and 
positional cloning techniques, several other genes and genetic regions have also been 
linked to atopic diseases. The loci most frequently identified are on chromosomes 5, 6, 
12 and 13 (Cookson and Moffatt 2000). However, as is the case with many other 
multifactorial disorders, efforts have failed to yield a consistent picture of genetic 
mechanisms. 
Environmental factors 
Nutritional proteins are among the first foreign antigens causing immune responses. 
Thus, the association between early feeding, especially cow’s milk-based formula 
feeding, and atopy has been widely studied, but results have been inconclusive. In a 
number of studies, early avoidance of cow´s milk-based formula has been reported to 
offer protection against sensitization (Saarinen and Kajosaari 1995, Tariq et al. 1998, 
Oddy et al. 1999, Saarinen et al. 1999), at least in children at genetic risk of atopy 
(Mallet et al. 1992, Oldaeus et al. 1997, Siltanen et al. 2003). A recent review 
examining this issue also came to the same conclusion (Odijk et al. 2003). However, 
some studies have shown contrary results (de Jong et al. 2002, Sears et al. 2002).  
Microbes, commensals as well as pathogens, have been suggested to have a major 
role in maturation of Th cell balance in early life. The theory of an inverse association 
between infection morbidity and atopic diseases was presented by Strachan (hygiene 
hypothesis) (1989). He analysed a large birth cohort of 17 414 subjects at 11 and 23 
years of age and found a significant inverse association between sibship size and hay 
fever. He inferred that the result may be a consequence of “infections in early childhood 
transmitted by unhygienic contact with older siblings”. Congruent results have later 
been reported in several studies (Räsänen et al. 1997, Bodner et al. 1998, Pekkanen et 
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al. 1999). Corresponding indirect evidence of an atopy-preventing effect of microbes is 
offered by studies showing reduced risk of atopy in children growing up in a farm 
environment (Kilpeläinen et al. 2000, Riedler et al. 2001). The same mechanisms may 
be related to early-life exposure to pets (Nafstad et al. 2001, Remes et al. 2001).  
Evidence of the role of commensal flora on Th cell balance is offered by studies 
evaluating gut microflora and atopy. Sudo et al. (1997) showed in germ-free mice that 
intestinal bacterial flora was obligatory for converting the early Th2 cell dominance to a 
Th1-type response and for the development of oral tolerance. Human studies have 
demonstrated significant differences in gut microflora between atopic and non-atopic 
subjects (Björksten et al. 2001, Kalliomäki et al. 2001a). Early manipulation of gut 
microflora via oral administration of probiotic bacteria has been shown to provide some 
protection against atopic eczema (Kalliomäki et al. 2001b, 2003). Antibiotic use during 
infancy may, by contrast, disturb gut flora, thereby preventing postnatal Th1 cell 
maturation (Oyama et al. 2001, McKeever et al. 2002). These results support the theory 
that factors interfering with colonization may have a role in the development of atopy.  
Pathogenic microbes obviously also affect atopic sensitization. Several specific 
infections (Shaheen et al. 1996, Matricardi et al. 1997, von Mutius et al. 2000) have 
been shown to be related to a reduced risk of atopy. The role of common viral 
respiratory infections in atopic sensitization is, however, more complicated. Early viral 
respiratory infections have been found in several studies to increase the risk of asthma 
or asthma-like respiratory symptoms (Nafstad et al. 2000). This is particularly the case 
with infections induced by respiratory syncytial viruses (Sigurs et al. 1995, Stein et al. 
1999) and rhinoviruses (Kotaniemi et al. 2003), but their role in atopic sensitization is 
controversial. While some studies have found an association between respiratory 
syncytial virus infection and atopic sensitization (Sigurs et al. 1995), others have not 
(Stein et al. 1999). Numerous mechanisms likely underlie the link between microbes 
and atopy. Possibilities include a bidirectional interaction, an atopic state influencing 
airway responses to viral infection, and a viral infection influencing atopic sensitization. 
The role of passive smoking in sensitization also remains obscure. Halken et al. 
(1995) concluded in their review that passive smoking causes an increased risk of 
obstructive respiratory disease as well as an increased risk of developing sensitization to 
specific allergens. In a relatively new prospective study, both prenatal and postnatal 
passive smoking was reported to have an adjuvant effect on allergic sensitization (Kulig 
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et al. 1999b). Strachan and Cook (1998), by contrast, reported that parental smoking is 
unlikely to increase the risk of allergic sensitization. They had excluded from their 
analyses subjects who had symptoms of asthma. Thus, passive smoking obviously 
increases the risk of obstructive respiratory disease and may also increase the risk of 
atopic sensitization. Tobacco smoke-related mechanisms causing sensitization probably 
differ from those of inhalant allergens.  
Exposure in early life to inhalant allergens such as house dust mites and pollen 
has been shown to be an important determinant of subsequent development of asthma 
(Sporik et al. 1990, Arshad et al. 1993), but the role played by exposure to pets is, at 
present, unclear (Wahn et al. 1997, Lindfors et al. 1999, Linneberg et al. 2001, 2003, 
Nafstad et al. 2001, Remes et al. 2001). The significance of exposure to pets probably 
depends on timing of exposure and co-existence of other risk factors, especially 
microbes.  
Epidemiology of premature birth 
Preterm birth is defined as birth before 37 weeks’ gestation. The proportion of preterm 
infants of all newborns in Finland during the last decade has been 5-6%, VLBW infants 
constituting approximately 15% of all preterm births (National Birth Register 1991-
2001). Preterm birth is multifactorial and difficult to predict despite several known risk 
factors (i.e. demographic, behavioural, maternal pre-pregnancy- and pregnancy-related 
factors) (Kliegman and Das 2002); the cause of 30-50% of preterm births remains 
unidentified (Hakala and Ylikorkala 1989, Slattery and Morrison 2002). The most 
common risk factors for preterm birth in Finland are multiple gestation, pre-eclampsia, 
hypertension, fetal malformations and growth retardation, previous preterm delivery, 
preterm uterine contractions, smoking, bleeding during early pregnancy, inadequate 
prenatal care and unmarried status (Hakala 1987, Hartikainen-Sorri and Sorri 1989).  
Approximately 20-30% of preterm births are due to medical or obstetric 
complications of pregnancy (e.g. pre-eclampsia, placental problems), where preterm 
delivery is indicated for the well-being of the mother or foetus, one-third to preterm 
uterine contractions and one-third to preterm premature rupture of membranes. The 
most common causes for premature rupture of membranes are multiple pregnancy, 
polyhydramnion and infection. Infection is estimated to be related to 20-40% of 
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premature births.  Cervix insufficiency has been linked to 8-15% of cases (Kekki and 
Paavonen 2003).  
NORMAL DEVELOPMENT OF ORGANS AND IMMUNE 
MECHANISMS INVOLVED IN ATOPIC DISEASES 
Foetal development of organs  
Immune system    
Development of the immune system occurs early in life. Lymphocytes, antigen-
presenting cells (APCs) and phagocytic cells all derive from pluripotent stem cells 
present in the human yolk sac at 21 days of gestation. Starting in the fifth week, the 
liver, spleen, thymus and bone marrow take over production of these cells (Hayward 
1998).  
By 22-23 weeks of gestation, mature polymorphonuclear neutrophils of the innate 
immune system are few in number, approximately 2% of those measured in the cord 
blood of neonates born at term (Ohls et al. 1995). At birth, in both term and preterm 
infants, these cells, as well as mononuclear phagocytic cells and natural killer cells, are 
functionally competent in normal circumstances, but under stress their functional 
capacity is impaired, leading to an increased susceptibility to infections during the 
neonatal period. The deficit is more pronounced in preterm infants (Kapur et al. 2002).  
Differentiation and functional maturity of T cells, which appear in week 8 of fetal 
life (Hayward 1998), is presumed to be complete by 18-20 weeks of gestation (Hanson 
et al. 1997). At birth, however, T cells still have low helper, suppressor and cytotoxic 
functions as well as diminished cytokine production (Hanson et al. 1996, 1997), 
increasing the susceptibility to intracellular and parasite infections (Hanson et al. 1997). 
Immunodeficient status due to functional immaturity of T cells persists at least until the 
age of 4-5 years (Pirenne et al. 1992). 
Foetal B cells have been found in in vitro studies to have the ability to produce 
IgM by gestational week 8, and IgG slightly later (Hanson et al. 1997, Hayward 1998, 
Kapur et al. 2002). IgG antibodies recognized in foetuses earlier, even at 5-6 weeks´ 
gestation, are of maternal origin and have been transported across the placenta; IgG is 
the only immunoglobulin capable of crossing the placenta (Hanson et al. 1997). IgA has 
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been found in foetal gut preparations derived from aborted foetuses at 13 weeks´ 
gestation (Hayward 1998), but other studies have demonstrated IgA synthesis at about 
30 weeks’ gestation (Kapur et al. 2002).  IgE antibodies have been measured in foetal 
blood at around 22 weeks´ gestation, and from then on the allergen-specific foetal 
proliferative responses have been found to correlate with increasing gestational age 
(Jones et al. 1996). Although the foetus is capable of producing different antibodies, the 
total antibody-producing capacity at birth even at term is still significantly lower than in 
adults.  
At the time of birth, most of the fetal circulating antibodies are IgG antibodies of 
maternal origin. The IgG concentration decreases postnatally because of catabolism of 
maternal IgG and reaches a nadir, a physiological hypogammaglobulinemia, at about 3-
4 months of age. Adult IgG levels are reached by 4-6 years (Kapur et al. 2002), 
depending on the subclass in question. IgG1 and IgG3 subclasses have been shown to 
reach adult levels faster than IgG2 and IgG4. The circulating IgM level at birth is only 
5-20% of the adult value (Hayward 1998, Kapur et al. 2002), reaching the adult level by 
1-2 years of age (Kapur et al. 2002). The adult level of IgA in serum is attained around 
puberty (MacDonald 1996, Kapur et al. 2002). 
Maturation of the immune system is a continuous process, starting in the first 
weeks of foetal life and extending into adulthood (Schultz et al. 2000). The first two 
years of postnatal life are considered to form a sensitive period during which the 
immunological priming of the Th cells takes place (Yabuhara et al. 1997, Macaubas et 
al. 1999), influenced by several intrinsic and extrinsic factors.  
Gut  
Development of the intestinal system also occurs early, the major morphological events 
taking place in the first 2 months after conception (MacDonald et al. 1996). Functional 
capacity, by contrast, continues to mature throughout the foetal period, reaching far into 
the postnatal phase (Bates and Balistreri 2002).   
Peyer´s patches and the first lymphocytes in lamina propria and between epithelial 
cells (components of the gut-associated lymphoid tissue) appear at 11 weeks´ gestation 
(Bates and Balistreri 2002). M cells, specialized antigen uptake cells overlying Peyer’s 
patches, have been observed at 17 weeks. The first T cells in the intestine appear at 
around week 19, probably having migrated from the thymus. B cells appear earlier and 
are relatively mature in the small intestine by 16 weeks´ gestation, but remain very few 
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in number even at the time of birth around 40 weeks’ gestation (MacDonald et al. 
1996). Postnatally, IgA and IgM production increase rapidly in the intestinal lamina 
propria (Perkkiö and Savilahti 1980, MacDonald et al. 1996, Hanson 1997), with IgM 
synthesis dominating (Perkkiö and Savilahti 1980). Within 3 months, however, the 
predominant immunoglobulin in lamina propria is IgA, reaching adult levels by 2 years 
(Savilahti 1972).  
The developmental state of the gut is also reflected in intestinal permeability. At 
birth, preterm infants have a higher permeability to proteins (Roberton et al. 1982, 
Müller et al. 1986, Axelsson et al. 1989, Kuitunen et al. 1994) as well as to 
disaccharides (van Elburg et al. 2003) than infants born at term. Protein permeability 
decreases with increasing maturity (Axelsson et al. 1989, Kuitunen et al. 1994). The 
effect of the increased intestinal permeability on priming of the immune responses of 
preterm infants is still unknown.  
Lungs 
Lung development is divided into three periods: embryonic, foetal and postnatal. The 
foetal period consists of four stages: pseudoglandular, canalicular, saccular and alveolar 
(Jobe 2002). Throughout the process, these periods and stages partly overlap.  
The first lung bud appears at 4 weeks´ gestation. In the embryonic period (from 4 
to 6 weeks), the proximal airways and pulmonary artery are formed. During the first 
part of the foetal period, in pseudoglandular stage (from 7 to 16-17 weeks), airway 
branching results in formation of bronchioles. Pulmonary arteries and veins grow in 
tandem with the airways. The acini are built at the canalicular stage (from 16-17 to 25-
27 weeks). During this stage epithelial cells lining the airways also differentiate, 
surfactant synthesis starts and the capillary network between airspaces is formed. In the 
saccular stage (25-28 to 35-40 weeks), the gas-exchange sites expand and final 
branching of airways takes place. In the alveolar stage, from 36-40 weeks’ gestation to 
1-3 years postnatally, thin-walled alveoli are finished and multiplied (Hansen and 
Corbet 1998a, Jobe 2002). Lung growth continues thereafter. The microvascular 
network matures until early preschool age. The rate of lung maturation is determined 
multifactorially, by genetic factors, cytokines and hormonal and pharmacological 
factors (Jobe 2002).  
Surfactant, functionally the most important biochemical component in the lungs, 
emerges at about 24 weeks´ gestation, with its synthesis increasing progressively 
  25  
thereafter. The appearance of surfactant in airspaces is enhanced by several factors 
(labour, delivery and breathing, corticosteroids, thyroid hormones and drugs such as 
theophyllin), enabling the infant’s survival after premature birth (Jobe 2002).  
Most preterm infants begin breathing with structurally and functionally very 
immature lungs, which leads frequently to early respiratory distress syndrome (RDS). In 
RDS, peripheral air spaces, relatively few in number, collapse easily, after which the 
more proximal respiratory bronchioles become overdistended and are covered by 
necrotic epithelium and hyaline membranes primarily because of the insufficient 
surfactant system. This often results in a difficult cascade of respiratory complications 
(Hansen and Corbet 1998a).  
Foetal and postnatal T helper cell balance  
Foetomaternal immune balance   
During pregnancy maternal cell-mediated immunity is transiently depressed (Lin et al. 
1993, Sabahi et al. 1995), and Th2-deviated immune balance dominates in the maternal 
and foetoplacental immune system, which is considered to be fundamental to the 
maintenance of a successful pregnancy (Wegmann et al. 1993). Wegmann et al. (1993) 
showed this in their murine studies; decidual cells spontaneously released interleukin-4 
(IL-4), IL-5 and IL-10 in multifold amounts compared with stimulated spleen cells, but 
interferon- γ (IFN-γ) in only very low quantities. The human foetoplacental unit has also 
been found to produce significant amounts of cytokines IL-4 (Jones et al. 1995), IL-10 
(Roth et al. 1996) and IL-13 (Williams et al. 2000). With these cytokines, the 
foetoplacental unit is assumed to redirect the maternal immunity towards Th2-
dominated immune responses (Lin et al. 1993). Besides their role in maintenance of 
pregnancy, Th2-type cytokines promote foetal development and growth.  
Th1-type cytokines, by contrast, are associated with harmful cytotoxic effects on 
pregnancy (Piccinni and Romagnani 1996), similar to their influence in allograft 
rejection. Analyses of aborted foetal tissues support this theory. The decidua of women 
with unexplained recurrent abortion have been found to produce significantly lower 
concentrations of IL-4 than clones derived from the decidua of voluntary abortions or of 
the endometrium of non-pregnant women (Deneys and Bruyere 1997). Thus, the normal 
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pregnancy-related Th2 cell-dominant balance obviously protects the foetus against 
rejection (Mellor and Munn 2000, Thellin et al. 2000). 
The cytokine pattern during pregnancy is controlled by several hormones. 
Progesterone affects the differentiation of Th cells into Th2 cells (Piccinni et al. 1995), 
whereas relaxin, another corpus luteum-derived hormone, mainly promotes the 
development of Th1-type cells (Piccinni and Romagnani 1996). Prostaglandin E2 is also 
known to contribute to immune balance by inhibiting IL-2 and IFN-gamma (Betz and 
Fox 1991), and probably suppressing the activity of natural killer cells (Linnemeyer and 
Pollack 1993). Prostaglandin E2 is viewed as a general immunosuppressant. 
The theoretically possible effect of maternal atopy on the course of pregnancy 
through Th2 cell-deviated balance has not been closely studied, but some conclusions 
have been drawn from indirect data. In an epidemiological study, atopic mothers were 
reported to have on average more children than non-atopic mothers, and thus, a positive 
association was concluded to be present between maternal atopy and successful 
pregnancy (Nilsson et al. 1997). However, controversial findings also exist. Sunyer et 
al. (2001), for instance, found an inverse relationship between maternal atopy and 
parity.  
In contrast to maternal atopy, the association between maternal asthma and 
preterm birth has been widely studied. Maternal asthma has repeatedly been linked to an 
adverse pregnancy outcome and an increased risk of preterm labour (Kelly et al. 1995, 
Kramer et al. 1995, Demissie et al. 1998, Källen et al. 2000, Liu et al. 2001). Kramer et 
al., however, found no association between metacholine responsiveness and preterm 
birth, suggesting that non-atopic, non-cholinergic mechanisms may link bronchial and 
uterine smooth muscle lability. Discrepant findings have also been reported; several 
studies have observed no association between optimally controlled asthma and preterm 
labour (Jana et al. 1995, Alexander et al. 1998, Minerbi-Codish et al. 1998). Tan and 
Thomson (2000) concluded in their review that adverse outcomes of pregnancy (e.g. 
preterm labour) can be attributed to chronically poor asthma control, whereas women 
with well-controlled asthma during pregnancy have outcomes similar to their non-
asthmatic counterparts.  
Transplacental sensitization 
Neonatal T cells are capable of responding to specific allergens at birth, indicating 
prenatal transplacental sensitization (Kondo et al. 1992, Piccinni et al. 1993, Warner et 
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al. 1994, Holt et al. 1995, Jones et al. 1996, Furuhashi et al. 1997, Prescott et al. 1998, 
1999). Several groups have shown this by measuring low-level lymphoproliferative 
responses from stimulated cord blood mononuclear cells (CBMC) to both inhalant and 
food allergens (Kondo et al. 1992, Piccinni et al. 1993, Warner et al. 1994, Holt et al. 
1995, Jones et al. 1996, Miles et al. 1996). Based on the common foetal Th cell balance, 
these neonatal allergen-specific T cell responses represent the Th2 cell-derived cytokine 
profile. Less is known about the timing of sensitization. Hauer et al. (2003) found that 
spontaneous cytokine-secreting cells were virtually absent in cord blood of infants 
under 34 weeks’ gestation, whereas Jones et al. (1996) have reported signs of 
proliferative cell responses at 22 weeks’ gestation.  
The origin of prenatal antigen-specific T cells has occasionally been impugned. 
Prescott et al. (1999) have, however, confirmed that the responding and proliferating 
cord blood cells were of foetal and not maternal origin by performing DNA analysis. 
Moreover, most infants showed no response to tetanus toxoid at birth (Holt et al. 1995, 
Prescott et al. 1998), which also indicates foetal origin of the cells.  
The role of transplacental sensitization in later atopic predisposition remains 
ambiguous. While some groups have reported that it predicts development of later 
atopic sensitization (Kondo et al. 1992, 1998, Warner et al. 1994, Miles et al. 1996), it 
has also been proposed to be related to normal adaptation to wide postnatal antigen 
exposure (Prescott et al. 1998). 
Postnatal conversion of T helper cell balance 
At birth, virtually all neonates express low-level Th2-skewed cytokine responses, 
similar to those in atopic adults (Prescott et al. 1998, 1999). However, from the early 
postnatal period onwards, maturation of the immune system leads to a rapid suppression 
of foetal Th2-type responses. Levels of IL-4 and IL-13 responses gradually fall, while 
IFN-gamma production increases (Prescott et al. 1999). The process is modified by 
genetic and environmental factors. In non-atopic infants, the Th1/Th2 cell balance is 
normally converted into Th1 predominance during the first year of life (Prescott et al. 
1999, Macaubas et al. 2000).  
The mode of postnatal suppression of Th2 responses diverges depending on the 
nature of the allergen. Responses to food and aeroallergens have different age-related 
changes (Yabuhara et al. 1997, Prescott et al. 1999). Proliferative responses to 
ovalbumin have been found to decline rapidly after birth and to be virtually absent by 
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12 months, whereas T cell reactivity to aeroallergens after birth increases progressively 
(Yabuhara 1997), the cytokine pattern gradually (in non-atopics) polarizing towards 
Th1-type responses (Macaubas et al. 2000). The divergent age-related patterns of 
change in these neonatal proliferative responses against food and inhalant allergens 
have been demonstrated to have no significant association with family history of atopy 
or expression of atopic signs (Prescott et al. 1999). The mechanisms underlying the 
regulation of lymphoproliferative postnatal changes are yet to be identified (Yabuhara et 
al. 1997). 
Normal patterns of immune responses to food and inhalant antigens 
All environmental antigens entering the host induce a set of physiological immune 
responses, either systemic priming, systemic tolerance (specific immunological 
unresponsiveness against harmless antigens) and/or induction of local secretory IgA 
responses in the absence of systemic immune responses (Strobel and Mowat 1998).  
Food antigens induce in most healthy children and adults antigen-specific IgG (mainly 
subclasses of IgG1 and IgG4), IgA, IgM and IgE antibodies (Husby 2000), with levels 
in healthy children gradually declining with increasing age (Barnes et al. 1995, 
Yabuhara et al. 1997, Jenmalm and Björksten 1998). The earlier the foreign antigen is 
introduced, the higher the antibody level rises (Tainio et al. 1988, Keller et al. 1996, 
Oldaeus et al. 1999) and the longer the elevated titre remains (Jenmalm and Björksten 
1998), indicating the influence of timing of exposure.  
Oral tolerance, physiological unresponsiveness against ingested antigens, starts to 
grow gradually after birth. In the mouse, it develops via multiple, complex  pathways; in 
man the exact mechanism remains unclear. Development of tolerance is always 
preceded by activation of antigen-specific T cells, after which tolerance is suggested to 
occur through anergy, deletion of T cells and/or suppression of T cell responses by 
regulatory T cells and their products, IL-10 and transforming growth factor-β  (TGF-β) 
(Garside and Mowat 2001); both Th1- and Th2-mediated responses are down-regulated 
(Garside et al. 1995).  
The predominant mechanism of tolerance depends on circumstances of antigen 
exposure. The nature, site, dose and timing of the antigen employed are thought to have 
an influence (Garside and Mowat 2001). High doses of antigen have been proposed to 
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promote clonal deletion, several dosings anergy of reactive T cells and lower doses 
activation of regulatory T cells which suppress immune responses (Mayer 2000). 
Mechanisms may also co-exist.  
Single feeds have been shown to inhibit IgM, IgG and IgE antibody responses as 
well as cell-mediated responses, IgE responses being particularly susceptible to 
induction of tolerance (Strobel and Mowat 1998). Decline in serum IgG and IgE 
antibody responses together with diminished T cell responses are considered the 
hallmarks of oral tolerance (Kato et al. 2001). In food allergies, development of 
tolerance has failed (Strobel and Mowat 1998). 
Several host-dependent factors (genetic background, age, maturation, hormonal 
status, gut flora, amount of antigen absorbed) are also suggested to influence the 
development of tolerance (Mayer 2000, Garside and Mowat 2001). A clear relationship 
between the amount of antigen absorbed and induction of tolerance has not been 
demonstrated.  The role of immaturity of the host also remains unclear; in rodent 
studies, it has been found to be related to a decreased ability to induce tolerance (Strobel 
and Ferguson 1984, Miller et al. 1994). However, Takahashi et al. (1995) showed that 
human cord blood T cells were highly susceptible to tolerance induction. 
Allergen-specific IgG antibodies to seasonal antigens can also be detected in early 
life (in 25% of subjects under 1 year of age), but in contrast to food antibodies, the 
concentrations are found to steadily increase with age, with 40-50% of children having 
measurable levels of specific IgG antibodies by age 5 (Rowntree et al. 1985). Yabuhara 
et al. (1997) have measured in over 90% of adults moderate to high levels of 
lymphoproliferative responses to house dust mite compared with concomitant low 
frequency and low intensity responses to ovalbumin. Allergen-specific inhalant IgE 
antibodies are detected in less than 5% of subjects under 1 year of age and in about 20% 
by 5 years of age. High levels are found to persist especially in those who develop 
clinical allergic symptoms (Rowntree et al. 1985, Hattevig et al. 1993).   
Divergent patterns of normal immune responses to different environmental 
antigens apply to qualitatively different types of control mechanisms; immune deviation 
(suppression) being dominant for nanogram-level exposure of inhalant allergens 
(leading to low zone tolerance) in contrast to T cell deletion or anergy for milligram-
level to gram-level exposure of dietary allergens (leading to high zone tolerance) (Holt 
1998). 
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DEVELOPMENT AND MECHANISMS OF THE IMMUNE 
SYSTEM IN ATOPIC CHILDREN 
Characteristics of T helper cell balance in atopic individuals at and 
after birth  
Differences in immunological status of atopic and non-atopic individuals can be seen at 
birth. Piccinni et al. (1996) found that CBMC of newborns with atopic parents exhibited 
an enhanced ability to produce Th2 cytokines (IL-4 and IL-5) compared with cells of 
newborns with non-atopic parents, but the ability to produce IFN- γ did not differ 
between the groups. In addition, Miles et al. (1996) discovered that infants who were 
born to atopic parents and/or who developed an allergic disease by the age of one year 
significantly more often had measurable allergen-specific peripheral blood mononuclear 
cell (PBMC) proliferative responses at birth than infants who did not develop any 
allergy or those without a family history of atopy.  
Holt et al. (1992) came to a different conclusion. They reported that infants at 
high genetic risk for atopy had markedly lower IFN-γ- and IL-4-producing capacity than 
controls at birth. They later specified that in atopics just the Th2 cell cytokine responses 
(IL-4, IL-6, IL-10, IL-13) were significantly lower at birth associated with defective 
IFN- γ production, and that the normal postnatal changes in Th cell cytokine profiles 
failed to occur in a timely fashion, resulting in prolongation of foetal Th2-type 
responses (Prescott et al. 1999). Williams et al. (2000) reported a congruent result; a 
low level of cord blood IL-13 was demonstrated to be associated with a later risk of 
atopy. Defective IFN- γ production at birth in infants at high risk for atopy or in those 
who later develop atopic disorders has been shown by several groups (Tang et al. 1994, 
Warner et al. 1994, Liao et al. 1996, Kondo et al. 1998, Macaubas et al. 2000).  
The basic defect in the immune system of atopic individuals has therefore been 
suggested to be a significantly decelerated postnatal maturation of the Th cell balance, 
and not prenatal sensitization (Prescott et al. 1998, 1999). Atopic infants do not exhibit 
an adult-type cytokine profile until around the age of 6 years (Macaubas et al. 2000), in 
contrast to non-atopic infants who attain this profile at 1-2 years. Based on this, the first 
years of life are considered to form a critical period for the development of Th cell 
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memory (priming of Th cells) and the allergen-responder phenotype in later life 
(Yabuhara et al. 1997, Macaubas et al. 1999).  
The association between cord blood IgE levels and subsequent predisposition to 
atopy has also been widely studied. High cord blood IgE levels are highly specific, but 
their sensitivity to predict atopy has been found to be low (Arshad et al. 1993, 
Kobayashi et al. 1994, Bergmann et al. 1997, Edenharter et al. 1998). 
Immune responses in atopic diseases 
According to the current theory, the principal cause of atopy is thought to be related to a 
disturbed balance in Th cell subsets, followed by inappropriate IgE secretion from B 
cells. The two main functional subsets, Th1 and Th2 cells, arise from a pluripotent 
precursor cell termed Th0. Differentiation and activation of Th1 cells, which produce 
predominantly IL-2, IFN-γ and tumour necrosis factor-beta (TNF-β) (Mosmann et al. 
1986, Imboden and Seaman 2001), lead to cell-mediated cytotoxic immune responses, 
macrophage activation and delayed type hypersensitivity (Imboden and Seaman 2001). 
Th1 cell-mediated responses are produced especially in bacterial and viral infections 
(Romagnani 1992). Th2-type cells produce predominantly IL-4, IL-5, IL-6, IL-10 and 
IL-13 (Huston 1997, Imboden and Seaman 2001) and contribute through activation of B 
cells and effector cells to protective humoral immune responses in parasite infections. In 
addition, they participate in allergic reactions (Huston 1997, Imboden and Seaman 
2001). Determinants for differentiation of naive Th cells into various successors and 
different types of immune responses are not fully understood. The process occurs under 
the influence of a complex interplay of genetic and environmental factors. Such factors 
as nature and dose of antigen (and adjuvant), site and timing of exposure and other 
ongoing immune responses are proposed to play a role in these processes (Romagnani 
1992). In atopic diseases, the Th cell balance is pathologically skewed to Th2 phenotype 
responses (Imboden and Seaman 2001). 
In allergic sensitization, immune responses are initiated by allergen bounding to 
HLA class II molecules on APCs. Macrophages, monocytes, dendritic cells and B 
lymphocytes possess APC properties. APCs process and present the allergen to naive T 
cells, Th0 cells, through T cell receptors (TCRs) and with the assistance of other surface 
molecules (especially CD4) on the T cell membranes (Huston 1997, Imboden and 
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Seaman 2001). After antigen presentation, the Th cells differentiate with a complex cell-
cell interaction and under the influence of stimulatory and inhibitory soluble mediators 
into a subpopulation of Th2 cells. Differentiated Th cells induce via cytokines and 
interaction of cell membrane molecules the maturation of B cells into antigen-specific, 
immunoglubulin-producing plasma cells (Huston 1997). A portion of the activated Th 
cells are transformed into memory T cells. The mature B cells activated by the Th2 cell 
route produce IgE and IgG4 antibodies (Huston 1997, Imboden and Seaman 2001). IgE 
antibodies bound to high-affinity cell membrane receptors on effector cells (Costa et al. 
1997).  
In a re-exposure, allergen molecules react with IgE antibodies on effector cell 
(mast cells, basophils, eosinophils) receptors. The cells are directly activated and start to 
secrete mediators of inflammation (histamine, leucotrienes, chemotactic factors, 
prostaglandins, platelet-activating factor, proteases). In an immediate phase of the 
allergic reaction, mediators act locally and cause increased vascular permeability, 
vasodilatation, smooth muscle contraction and mucous gland secretion. In the late 
phase, cellular inflammation develops; inflammatory cells (neutrophils, eosinophils, 
mononuclear cells) infiltrate into the tissue in response to chemical mediators (Terr 
2001). 
PATHOLOGICAL CHANGES IN ASTHMA AND IN 
NEONATAL CHRONIC LUNG DISEASE                      
In addition to histochemical inflammation in asthma, specific structural changes 
develop in the airway walls. This process, referred to as airway remodelling, comprises 
subepithelial fibrosis, myofibroblast accumulation, airway smooth muscle hyperplasia 
and hypertrophy, mucous gland and goblet cell hyperplasia and epithelial disruption. 
The airway remodelling may be a consequence of chronic inflammation, but the precise 
relationship between the remodelling and inflammatory components in asthma remains 
unclear (Redington 2000, Jeffery 2001). 
Pathogenesis of CLD is obviously multifactorial. Immaturity of the lungs, 
including a deficient surfactant system, has a primary role, but genetic factors and 
postnatal treatments and events (exposure to oxygen toxicity, barotraumas/volutrauma, 
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infections, excessive hydration, nutritional insufficiency) also contribute markedly to 
the development of the disease (Hansen and Corbet 1998b), resulting in aberrant lung 
development (Jobe 1999). Postmortem examinations of BPD lungs have revealed 
massive fibrosis and destruction of alveoli and airways, bronchial smooth muscle 
hypertrophy, metaplasia of the airway mucosa, loss of pulmonary arterioles and 
capillaries and muscular hypertrophy of the remaining vessels (Hansen and Corbet 
1998b), leading to impaired airway growth in infancy. Histochemically, a persistent 
neutrophilic inflammation prevails. However, in some studies, eosinophils have also 
been concluded to participate in the pathogenesis of CLD (Yamamoto et al. 1996, 
Raghavender and Smith 1997).  
The pathogenesis of long-term respiratory symptoms and lung function 
abnormalities of prematurely born infants at school-age is less well known. Long-term 
respiratory symptoms are suggested to be mainly due to structural pulmonary changes 
(Northway et al. 1990, Chan and Silverman 1993), but inflammatory mechanisms 
obviously also play a role in the process  (Pelkonen et al. 1999).  
ATOPY IN PREMATURELY BORN CHILDREN 
Atopic sensitization and atopic diseases 
Previous studies evaluating the relationship between atopy and prematurity have yielded 
inconsistent results, reporting both positive and inverse associations. Summaries of 
these studies are presented in Tables 1a-c. The studies were collected by performing an 
electronic literature search by cross-linking the search words “birth weight”, 
“gestational age”, “preterm”, “prematurity”, “atopy” and “allergy”. 
Preterm birth was earlier thought to be a risk factor for atopic sensitization since 
immunological and digestive immaturity was assumed to lead to an impaired 
development of tolerance (Strobel and Ferguson 1984, Arsdhad et al. 1993, Clough 
1993). This theory has been supported by population-based epidemiological studies and 
by some cohort studies of selected groups of children (Table 1a). In these studies, 
asthma, allergic rhinitis and/or atopic eczema were each found to be related to low 
gestational age or to low birth weight. Food allergen avoidance and aeroallergen 
elimination programmes, which have previously been recommended as the primary 
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means for prevention against sensitization (Hide et al. 1996), were based on this theory 
of impaired development of tolerance. 
Several other studies have, however, found no significant association between 
atopy and gestational age or low birth weight (Table 1b). These results lead to the 
assumption of equal functional capacity to develop tolerance or sensitization 
irrespective of immunological maturity stage during the neonatal period. 
David and Ewing (1988) were the first to report an inverse association between 
prematurity and atopy; they noted the exceptionally low number of subjects born 
preterm among 443 children hospitalized because of atopic dermatitis. Klebanoff and 
Berendes (1988) responded that in their large birth cohort of 144 793 subjects the 
difference in eczema prevalence between subjects born preterm and full-term was 
minimal and not significant. A few cohort studies and several epidemiological studies 
have, however, subsequently confirmed the findings of David and Ewing (Table 1c).  
General antibody production capacity of preterm infants has been evaluated by 
analyzing their antigen-specific vaccine responses. Preterm infants have been reported 
to yield adequate protective antibody responses against vaccine antigens (Faldella et al. 
1998, Khalak et al. 1998, Schloesser et al. 1999, Thayyil-Sudhan et al. 1999, Kirmani et 
al. 2002), although the antibody concentrations were significantly lower than in term 
infants (Faldella et al. 1998, Schloesser et al. 1999, Kirmani et al. 2002).   
Atopy in relation to wheezing, asthma and lung function  
Long-term respiratory symptoms and lung function in prematurely born children have 
been studied extensively. Children born preterm, as compared to those born full-term, 
are known to have more long-lasting asthma-type respiratory problems (Chan et al. 
1989a, Kitchen et al. 1992, Frischer et al. 1993, Rona et al. 1993, Elder et al. 1996, 
McLeod et al. 1996, Svanes et al. 1998) and reduced lung function (Chan et al. 1989b, 
Northway et al. 1990, Rona et al. 1993, Parat et al. 1995, Hakulinen et al. 1996, 
McLeod et al. 1996, Pelkonen et al. 1997, Jacob et al. 1998, Kennedy et al. 2000). 
Those who have had BPD/CLD in particular have an increased risk of long-term 
respiratory problems (Bader et al. 1987, Northway et al. 1990, Koumbourlis et al. 1996, 
Giacoia et al. 1997, Gross et al. 1998, Jacob et al. 1998). Prematurity is thus commonly 
considered a risk factor for childhood asthma. However, this conclusion has not been
Table 1a. Cohort studies of prematurely born children and/or low birth weight children and population-based studies that evaluated the association between atopic 
findings and perinatal factors and found prematurity and/or low birth weight to increase the risk of atopy. 
 
Authors Objective  Study Methods/ Age Outcome Results/ 
(Year) of study cohort/ data of  measures conclusions 
Country  groups collection children   
   
Lucas et al. To study the effect of Follow-up of Questionnaire 18 mo History of AD Incidence of eczema 
(1990) early diet and incidence 777 children Physical examination  and wheezing and wheezing higher in 
United Kingdom of allergic reactions with BW Exclusion-challenge  Challenge-confirmed preterms than in normal 
 in preterm infants <1850 g test  food sensitivity population 
      
Forster et al. To study the effect Follow-up of Perinatal data on 18 mo History of AD, Incidence of atopic symptoms 
(1990) of gestational age, 318 newborns hospital records  asthma and hay overall higher in children born 
Germany nutrition and treated in the Questionnaire  fever preterm (p<0.01), (p<0.001 for  
 social class on ward (137 born (phone calls to check   difference in incidence of AD) 
 atopic symptoms preterm, <38 wks) questionnaire data)   
         
Kuehr et al. To study Cohort of 1470 Questionnaire 6 - 8 y Positive SPT  Gestational age <37 wks is a  
(1992) early childhood schoolchildren SPT   risk factor for aeroallergen 
Germany, Austria risk factors of     sensitization 
 atopic sensitization     (OR 1.9, 95% CI 1.1-3.2) 
        
Arshad et al. To determine Prospective Perinatal data on 2 y Doctor-diagnosed BW <2500 g but not 
(1993) the effect of genetic follow-up of a hospital records  asthma, AD, rhinitis prematurity increased the 
United Kingdom and environmental birth cohort of Questionnaire  and food allergy risk of asthma (p<0.01) and 
 factors on prevalence 1174 children SPT (n=436)  Positive SPT  positive SPT (p<0.01) but 
 of allergic disorders  Cord blood IgE   not the risk of AD or rhinitis 
 
Stazi et al. To study the influence Population-based Questionnaire 3 mo - 5 y History of AD, Prematurity (<37 wks) and low 
(2002) of early life events on sample of 201 Interview  allergic rhinitis BW (<2500 g) increased the   
Italy IgE-mediated allergy children SPT  and asthma risk of rhinitis but were not  
     Positive SPT associated with SPT-positivity 
 
AD = atopic dermatitis, BW = birth weight, SPT = skin prick test, wks = gestational weeks 
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Table 1b. Cohort studies of prematurely born children and/or low birth weight children and population-based studies that evaluated the association between atopic 
findings and perinatal factors and found no significant association between prematurity and/or low birth weight and atopy. 
 
Authors Objective Study Methods/ Age Outcome Results/ 
(Year) of  cohort/ data of  measures conclusions 
Country study groups collection children   
 
de Martino et al. To evaluate  80 preterm  Questionnaire 9 - 24 mo History of AD, No significant difference in 
(1989) atopic diseases (27 - 38 wks), SPT  urticaria and frequencies of SPT reactions or in 
Italy in preterm infants 80 full-term   wheezing atopic diseases between infants 
  infants   Positive SPT born preterm and full-term infants 
 
Savilahti et al. To evaluate the effect 69 preterm Questionnaire 11 y History of allergic Cumulative incidence of allergic 
(1993) of early feeding and  infants SPT  rhinitis, urticaria, symptoms similar to that  
Finland appearance of allergic (31 - 36 wks) Serum total and  AD and wheezing reported in unselected series 
 sensitization on infants  cow milk-specific  Positive SPT (prolonged exclusive breast feeding  
 born preterm  IgE, IgG, IgA, IgM   increased the risk of atopy) 
 
Sears et al. To study risk factors Follow-up of Questionnaire 18 y History of asthma No association between 
(1996) for development of birth cohort SPT (at 13 y)  and hay fever BW and atopy (defined as  
Canada childhood atopy of 1037 Spirometry with  Positive SPT positive SPT), asthma  
  children metacholine challenge  BHR  or BHR 
 
Butland et al. To investigate whether 2 birth cohorts, Perinatal data  16 y History of current Neither hay fever nor AD was 
(1997) changes in perinatal and 11 195 children collected by  hay fever associated with BW 
United Kingdom social factors explain the born 1958, and  midwives at birth   and AD (BW did not explain the 
 increase in prevalence 9387 born 1970 Parental interview at   increase over a 16-y period in  
 of hay fever and AD  5 or 7 y, and at 16 y   prevalence of hay fever or AD) 
 
Fergusson et al. To study linkage Longitudinal Structured interview 16 y Number of medical Neither gestational age nor BW  
(1997) between perinatal follow-up of a Data from hospital  consultations because  were related to asthma, AD 
New Zealand factors and the risk of birth cohort of records, general practi-  of asthma, allergic  or allergic rhinitis (large head 
 atopic conditions 891 children tioner’s notes and  rhinitis, AD or circumference was linked to an 
   diary kept by parents  other atopic illnesses increased risk of asthma) 
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Gregory et al. To examine the relation Part (239 Asthma questionnaire 6 - 26 y Treated asthma No association between 
(1999) between antropometric children) of the Data from hospital  Current wheezing gestational age or BW and asthma, 
United Kingdom/ measurements at birth Southmapton records  Positive SPT S-IgE level or SPT reactions 
New Zealand and asthma and asthma genetic SPT  Elevated S-IgE level  (large head circum ference 
 incidence of atopy study S-IgE   was linked to high IgE level) 
 
Leadbitter et al. To assess the Birth cohort Perinatal data on 13 y History of asthma, BW <3 kg decreased the risk of 
(1999) relationship of  734 hospital records  wheezing, hay fever asthma, but had no association  
New Zealand between foetal subjects Questionnaire  and AD with SPT reactions, S-IgE level, hay  
 growth and atopy  SPT and S-IgE  Positive SPT fever or AD (head circumference 
 and asthma  Metacholine challenge  BHR was associated with S-IgE level) 
 
Steffensen et al. To evaluate the 4795 male Registry data on male 18 y History of asthma No significant association  
(2000) association between conscripts conscripts  and AD between gestational age  
Denmark foetal growth and AD  Medical Birth Registry   and asthma or AD 
 and asthma  data    
   Medical records    
 
Mai et al. To assess the  Prospective  Questionnaire 12 y History of asthma, VLBW was unrelated to  
(2003) relationship follow-up of 74 SPT, IL-4, IL-5, IFN-γ  allergic rhino- atopic symptoms, SPT reactions  
Sweden between VLBW VLBW children Spirometry with  conjunctivitis  or cytokine levels, but history 
 and asthma, lung and  64 term hypertonic saline  and AD of asthma was more frequent in 
 function and atopy children  provocation test  Positive SPT VLBW children  
 
 
AD = atopic dermatitis, BHR = bronchial hyperresponsiveness, BW = birth weight, S-IgE = serum total IgE, SPT = skin prick test, VLBW = very low birth weight, wks = gestational weeks 
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Table 1c. Cohort studies of prematurely born children and/or low birth weight children and population-based studies that evaluated the association between atopic findings 
and perinatal factors and found prematurity and/or low birth weight to decrease to the risk of atopy. 
 
Authors Objective Study Methods/ Age Outcome Results/ 
(Year) of  cohort/ data of  measures conclusions 
Country study groups collection children   
 
David and Ewing To study the  443 children Regional Health - Doctor- Among children with AD, a 
(1988) proportion of preterms with AD Authority Registry  diagnosed AD significantly lower number of  
United Kingdom (<37 wks) among referred to the data   subjects born preterm (p=0.03)  
 children with atopic ward of Questionnaire   compared with 81 038 control  
 eczema child health    children (3% vs 6%) 
 
Olesen et al. To study the Birth cohort of Registry data  5 - 8 y   Doctor- AD was associated with high 
(1997) association between 7862 children Data on children in  diagnosed AD gestational age (p=0.02) and with 
Denmark birth factors and  dermatology and   ”heavy-for-date” BW  
 development of AD  pediatric wards   
   with diagnosed AD 
 
Bråbäck and To study the Cohort of Linkage of data on 17 - 20 y Doctor-diagnosed Prematurity and low BW protected 
Hedberg relationship between 149 398 male Medical Birth  current asthma from allergic rhinitis (<33 wks,  
(1998) perinatal risk conscripts Register and Military  and allergic 33-36 wks, >36 wks; 11.6%, 13.2%, 
Sweden factors and allergic  Service Register  rhinitis 15.2%, respectively, p=0.0001) 
 rhinitis and asthma     Low BW was related to asthma 
 
Buhrer et al.  To investigate the 331 VLBW Physical examination 1 y Current eczema VLBW infants had less current eczema 
(1999)  1-y prevalence infants (<1500g) Questionnaire  History of eczema  (2% vs 4%, p=0.045) and less history  
Germany of atopic eczema and 455 term    of eczema (1.5% vs 4.6%, p=0.016)  
 in VLBW infants controls    than healthy controls 
 
Hikino et al. To study the 21 766 infants Questionnaire 18 mo History of doctor- Food allergy (p<0.001) and  
(2001) prevalence of food (aged 18mo) and Clinical examination 3 y diagnosed food allergy  AD (p<0.01) at 18 mo 
Japan allergy and AD in 4378 children by paediatrician  Current AD less frequent in children  
 low BW infants (aged 3 y) from    with low BW (<2500 g) (trend  
  well-baby     was related to gestational age) 
  check-ups 
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Pekkanen et al. To study the Prospective Questionnaire 31 y Doctor-diagnosed Risk of atopy (defined as positive  
(2001) association of atopy birth cohort of SPT  asthma SPT) increased with gestational  
Finland and asthma with pre- 5195 subjects   Positive SPT age ≥35 wks (p for trend 0.002),  
 and perinatal     but not with BW 
 characteristics     No association for asthma 
       
Räsänen et al. To study the effect Five birth Questionnaire 16 y Parent-reported and Risk of hay fever increased with 
(2001) of perinatal factors cohorts of twins,   doctor-diagnosed increasing BW (p for trend 0.048) 
Finland on the risk of 2550 families and  hay fever and gestational age (p for trend  
 hay fever 4722 adolescents    0.04), especially in those with no 
      parental history of hay fever  
 
Kerkhof et al. To study the Part of the birth Questionnaire 1 y Doctor-diagnosed AD Gestational age was not associated  
(2003) association  between cohort of the Physical examination   with AD, but BW >4000 g 
Netherlands AD and birth PIAMA study:    increased the risk of AD compared 
 characteristics and 304 children of    with weight of 3000-4000 g 
 environmental factors allergic mothers       (OR 2.4, 95% CI 1.1-5.1) 
        
 
AD = atopic dermatitis, BW = birth weight, PIAMA = Prevention and Incidence of Asthma and Mite Allergy, SPT = skin prick test, VLBW =very low birth weight, wks = gestational weeks 
 confirmed by all studies. A recent Finnish twin study and a study from New Zealand 
found no association between gestational age and doctor-diagnosed asthma in 
adolescents (Leadbitter et al. 1999, Räsänen et al. 2000). 
In a few studies concentrating on long-term respiratory morbidity of preterm 
children (Chan et al. 1989a, Northway et al. 1990, von Mutius et al. 1993, Pelkonen et 
al. 1997), the incidence of atopy was also examined, but the relationship of long-term 
respiratory findings to atopy was not analysed. Pelkonen et al. (1997) analysed the 
frequency of atopy in preterm infants with BPD and in those without BPD (17% vs. 
29% were defined as atopic, respectively). Von Mutius et al (1993) reported that 
premature girls given ventilatory support had atopy less frequently than term girls or 
those preterm girls who had not been mechanically ventilated. 
Atopic heredity has been found in some studies to predispose preterm infants to 
neonatal respiratory morbidity (Bertrand et al. 1985, Lucas et al. 1990, von Mutius et al. 
1993, Elder et al. 1996), but discrepant results have also been presented; several studies 
have reported no difference in family history of atopy or asthma between preterm 
infants with and without neonatal respiratory problems (Chan et al. 1989a, Hakulinen et 
al. 1990, Northway et al. 1990, Hagan et al. 1995, de Winter et al. 1995, Pelkonen et al. 
1997). Thus, the role of atopic heredity in long-term respiratory problems of preterm 
children remains unestablished. 
In conclusion, previous studies evaluating the association between atopy and 
prematurity have failed to establish a consistent result. Thus, further research is needed 
to determine the long-term effects of immaturity on the immune balance of the child. 
The possible association between maternal predisposition to atopy and preterm birth 
also warrants examination. Results of epidemiological studies shed light on the risk 
factors and protective factors of atopy, which can then be applied to planning of 
prevention. 
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AIMS OF THE STUDY 
The main objective of this study was to evaluate the association between prematurity 
and atopy. Specific objectives were: 
 
1. To evaluate whether prematurity at birth is associated with a risk of later atopic 
sensitization of the child by defining prevalence of atopy in children born preterm at 
the age of 10 years and comparing that with the corresponding prevalence in a 
control group of children born at term (I).  
 
2. To assess the role of atopy in wheezing, asthma, and lung function in children born 
preterm compared with children born full-term (II). 
 
3. To compare immune responses to early-introduced food antigens at the age of 10 
years of children born preterm with those of children born full-term (III). 
 
4. To evaluate whether maternal atopy is related to preterm birth (IV).    
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SUBJECTS  
Groups of children (I, II, III) 
One hundred consecutive very prematurely born children  (58 boys, 42 girls) with birth 
weights of less than 1501 grams, who had been treated in 1987-1988 in the neonatal 
intensive care unit at the Hospital for Children and Adolescents, University of Helsinki, 
were invited to participate in the study at the age of 10 years.  
The control group consisted of 96 unselected, age-matched schoolchildren (55 
boys, 41 girls) from two schools in the Helsinki region (three classes from an urban 
school in Meilahti and one from a rural school in Kirkkonummi). All of the children 
from the classes, whose birth weight was over 2500 grams, were invited.  
In the preterm group, 72 children (46 boys and 26 girls; 72%) participated and in 
the full-term group 65 (34 boys and 31 girls; 68%) (Table 2). The difference between 
the groups in participation was not significant (p=0.513). 
 
 
Table 2. Characteristics of the children. 
 
 Preterm group Full-term group   
 (n=72) (n=65)  
Male/female 46/26 34/31 
Mean birth weight, g (SD, range) 1075 (271, 550-1500) 3593 (470, 2540-5200)* 
Mean age, y (SD, range) 10.1 (0.3, 9.6-10.8) 10.1 (0.4, 9.4-10.9) 
Mean weight, kg (SD, range) 30.3 (6.3, 18.3-48.1) 35.4 (7.0, 24.0-54.2) * 
Relative weight †, % (range) -1.8 (-27.0-42.0) 6.5 (-12.0-48.0) * 
Mean height, cm (SD, range) 136.4 (7.7, 119.2-154.9) 140.2 (6.6, 125.2-160.1) § 
Relative height ‡, SD (range) -0.5 (-3.0-2.2) 0.1 (-2.3-3.2) *   
* p≤0.001 by t-test. 
† Relative weight expressed as deviation of weight in % from the mean for height and sex (Pere 2000).  
‡ Relative height expressed as deviation of height in SD units from the mean height for age and sex (Pere 2000). 
§ p=0.003 by t-test. 
 
 
Mean gestational age of the children born preterm was 28.5 weeks (SD 2.4, range 
23.4-33.7), and mean birth weight was 1075 g. For the full-terms, mean birth weight 
was 3593 g (only two cases had weighed less than 2900 g) (Table 2). The neonatal data 
of the preterm group are described in Table 3. The gestational ages of children born at 
term were not recorded. 
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Table 3. Neonatal data on the preterm group (n=72).  
 
Mean gestational age, weeks (SD, range) 28.5 (2.4, 23.4-33.7) 
Antenatal steroid treatment, n (%) 2 (3) 
Caesarean section, n (%) 40 (56) 
Birth weight < -2SD *, n (%) 19 (26) 
Human surfactant treatment †, n (%) 19 (26) 
Respiratory distress syndrome, n (%) 49 (68) 
Bronchopulmonary dysplasia, n (%) 33 (46) 
Oxygen supplementation at 36 gestational weeks, n (%) 25 (35) 
Parenteral dexamethasone treatment ‡, n (%) 14 (19) 
Blood culture verified sepsis, n (%) 11 (15) 
Mean length of hospital stay, months (SD, range)  3.0 (2.5, 1.0 – 14.2)  
 * Deviation of birth weight in SD units from the  mean birth weight for gestational age and sex estimated by Finnish foetal growth 
curves (Pihkala et al. 1989). 
† Treatment given in accordance with the ongoing study protocol (Merritt et al. 1991). 
‡ Treatment given for weaning from ventilator. 
 
 
Mean age at the time of examination was 10.1 years in both groups (Table 2). The 
relative height and weight were significantly lower in the preterm group than in the full-
term group (Table 2). The groups did not differ significantly in month of birth, month of 
examination, number of siblings, parental smoking, furred pets at home, type of living 
area or socio-economic status of the family as judged from the educational level of the 
parents. 
The proportion of atopic parents was similar in both groups, apart from maternal 
and paternal allergic rhinoconjunctivitis, which was more common in parents of 
children born full-term (Table 4). This result provided the basis for further analysis of 
the association between parental atopy and preterm birth (IV). 
Respiratory infections during the first two years were more common in children 
born preterm than in those born full-term:  42% versus 15% (p=0.001). A corresponding 
difference was seen in the frequency of adenotomy and tympanostomy; 58% of the 
preterm group and 31% of the full-term group had undergone these operations 
(p=0.001). 
 
  46  
Table 4. Proportions of parental atopic symptoms (%) in the two groups and differences between the 
groups. 
 
Symptoms in one Preterm group Full-term group  p-value* OR† 95% CI  
or both parents (n=72) (n=65)   
Asthma, % 7 3 NS 2.35 0.44-12.55 
Atopic eczema, % 29 31 NS 0.93 0.45-1.93 
Allergic rhinoconjunctivitis, % 35 62 0.002 0.33 0.17-0.67 
Family history of atopy ‡, % 51 66 0.080 0.54 0.27-1.08 
Family history of  
definitive atopy §, % 15 22 NS 0.66 0.27-1.57 
Symptoms in mother 
Asthma, % 4 3 NS 1.37  0.22-8.46 
Atopic aczema, % 22 18 NS 1.26 0.55-2.92 
Allergic rhinoconjunctivitis, % 24 38 0.06 0.49 0.24-1.05 
Symptoms in father  
Asthma, % 3 0 
Atopic aczema, % 11 18 NS 0.55 0.21-1.45 
Allergic rhinoconjunctivitis, % 14 31 0.017 0.36  0.15-0.85 
* Chi-squared test. 
† Logistic regression method. 
‡ Asthma, allergic rhinoconjunctivitis and/or atopic eczema in one or both parents. 
§ Asthma or symptoms in more than one organ in one or both parents. 
NS = non-significant  
 
 
The first introduction of foreign food antigen in preterm children was registered 
precisely from hospital case records. Early feeding data from the hospital records were 
available for 57 of the 72 preterm children. Cow’s milk-based formula was introduced 
on day 36 (SD 27, range 9-149, median 26). Protein fortifier in breast milk or formula 
milk was given to 29 children at the mean age of 26 days (SD 14, range 10-74, median 
22).  
The above-described figures for the background factors apply to the entire groups 
of children participating in the studies. Minimal differences in distribution of these 
background factors between studies (I, II, III) are present because all children could not 
perform spirometry testing and a blood sample was either not given by all or was 
insufficient for food antibody measurements.  
Groups of parents (IV) 
Personal data on VLBW infants born in the three maternity hospitals in the Helsinki 
area (the Department of Obstetrics, Helsinki University Central Hospital; Helsinki City 
Maternity Hospital; and Jorvi Hospital) were collected from the registry of newborn 
infants, maintained at the Central Bureau of the Ministry of Health, Finland. From 
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November 1995 to the end of 1999, altogether 370 infants with a birth weight of less 
than 1500 g were born in these hospitals. Questionnaires concerning parental atopy 
were sent to the parents of each child.  
Parents of 544 infants with a birth weight above 3000 g, born from July 1999 to 
the end of 1999 in the same hospitals, indentified in the same registry, were selected as 
controls. Questionnaires concerning parental atopy were also sent to the parents of these 
children.  
The response rate to the questionnaires was 56% for both groups. Respondents 
comprised 213 mothers (58%) and 205 fathers (55%) of VLBW infants and 311 
mothers (56%) and 305 fathers (56%) of full-term infants. Infants born from multiple 
pregnancies (6 full-term and 43 preterm) were excluded from the final analysis. 
METHODS  
Prenatal and neonatal data (I, II, III) 
Prenatal and neonatal data on pregnancy, delivery, early medical problems, treatments 
and nutrition of children born preterm were collected from the hospital case records. 
The diagnosis of BPD was based on the criteria of Bancalari (1979). The diagnosis of 
CLD was not used at that time. The need for oxygen supplementation at 36 
postconceptional weeks was, however, recorded referring to CLD (Shennan et al. 1988). 
Questionnaire data (I, II, III, IV) 
The parents of both groups of children were asked to fill out the questionnaire, 
including data on their own atopic symptoms, atopic symptoms and other diseases of 
their child and possible environmental risk factors for atopy. The questionnaire was 
checked and discussed in detail with the parent(s) at the outpatient clinic by the 
researcher (M.S.) (I, II, III).  
When evaluating parental atopy and preterm birth, separate questionnaires were 
sent to both the mother and the father of each child, inquiring about parental symptoms 
suggestive of atopy (hay fever, asthma, atopic eczema/dermatitis) and whether any of 
their allergic diseases was diagnosed by a doctor (IV). 
  48  
Diagnostic definitions (I, II, III, IV) 
Atopic eczema was diagnosed when the child had a history of chronic or chronically 
relapsing itching dermatitis with typical morphology and distribution (Hanifin and 
Rajka 1980). Diagnosis of allergic rhinoconjunctivitis was based on a history of a runny 
and/or blocked nose and/or itchy, watery eyes with seasonal variation or with animal 
contacts and apart from infection episodes. Recurrent wheezing was confirmed when 
the child had a history of at least three episodes of wheezing. Breathing difficulties 
caused by acute laryngitis were excluded. Asthma was recorded when diagnosed by a 
doctor. The child was considered to have atopic asthma when, in addition to clinical 
asthma, at least one of the following objective findings of an atopic reaction was 
measured in the study: serum total IgE over 320 kU/l, at least one allergen-specific IgE 
level over 0.8 kU/l or at least one positive skin prick test (SPT) reaction. 
The child was considered to be atopic if he/she had experienced at least one of the 
above-mentioned symptoms (symptoms in at least one organ). When the history of 
atopic symptoms was validated with at least one objective finding of an atopic reaction 
(as in the definition of atopic asthma), the child was classified as having obvious atopy. 
A family history of atopy was defined as asthma, allergic rhinoconjunctivitis 
and/or atopic eczema in one or both parents (symptoms in at least one organ). A family 
history of definitive atopy was recorded when one or both parents had had asthma or 
symptoms in more than one organ. 
In the study of parental atopy and preterm birth (IV), history of atopic symptoms 
(hay fever, asthma, or atopic dermatitis) was recorded separately for both parents. 
Atopy was classified as verified atopy when doctor-diagnosed. 
Skin prick testing (I, II, III) 
SPT was performed by two nurses at the hospital. The test consisted of a panel of eight 
standard Soluprick solutions from ALK (Allergologiska Laboratorium, Copenhagen, 
Denmark); including extracts of birch, timothy, meadow fescue, mugwort pollen, cat 
and dog dander, house dust mite Dermatophagoides pteronyssinus, hen´s egg and latex 
Prick test standard solution from Stallergenes SA (France). Histamine hydrochloride 
(10 mg/ml) served as a positive control and 50% glycerol solution as a negative control. 
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The reaction was regarded as positive when the wheal diameter was 3 mm or more and 
the negative control solution caused no reaction. All of the children participating in the 
study were tested. 
Blood samples (I, II, III) 
Serum total IgE concentration and allergen-specific IgE antibodies to hen´s egg, cat 
dander and birch pollen were measured by enzymatic UniCAP fluoroimmunoassay, 
and serum eosinophil cationic protein (ECP) by UniCAP fluoroimmunoassay  
(Pharmacia-Upjohn, Uppsala, Sweden). Serum total IgE over 320 kU/l, allergen-
specific IgE antibodies over 0.8 kU/l and ECP concentration over 15 µg/l (II) were 
considered indicative of atopic sensitization. Blood eosinophil count was also measured. 
Antibodies of IgA and IgG isotypes to cow’s milk and its components β-
lactoglobulin  (BLG) and α-casein (ACAS), and ovalbumin were measured with an 
enzyme-linked immunosorbent assay (ELISA), with modifications (Saukkonen et al. 1994, 
Vaarala et al. 1995). Microtitre plates (Nunc Immunoplate, Nunc A/S, Roskilde, 
Denmark) were coated with either diluted, defatted (1:500) adapted liquid milk formula 
(Tutteli, Valio Ltd, Helsinki, Finland), with BLG (Sigma Pharmaceuticals, St. Louis, 
MO, USA) at a concentration of 1 µg/ml or with ACAS and ovalbumin (Sigma) at a 
concentration of 2 µg/ml in carbonate buffer, pH 9.6, overnight. Diluted sera were applied 
in triplicate to the antigen-coated plates and in duplicate to wells of the same microtitre 
plates coated with blocking solution (1% sheep serum); the plates were incubated 
overnight at room temperature.  After washing, 75 µl of alkaline-phosphatase-conjugated 
monospecific swine anti-human IgG, IgA and IgM antisera (diluted 1:200) (Orion 
Diagnostica, Helsinki, Finland) were added, and the plates were incubated for 60 minutes 
at 37°C.  After washing, 75 µl of p-nitrophenylphosphate substrate was added (2 mg/ml in 
diethanolamine buffer, pH 10.0, from I.T. Baker Chemical, Deventer, the Netherlands).  
The reaction was stopped after 30 minutes with 75 µl of 1 mol/l NaOH. The end-product 
was measured at 405 nm in a semi-automatic photometer (Titertek Multiscan, Elflab 
Inc., Helsinki, Finland). The result was compared with that for 2-fold serial dilutions of a 
standard serum with a very high titre of the respective antibodies.  The standard serum was 
given the value of 100 arbitrary units (AU).   IgG gliadin antibodies were measured by 
ELISA (Kolho and Savilahti 1997).  
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IgG antibodies to tetanus and diphteria toxoids were measured with ELISA.  
Toxoids were a gift from Dr. Helena Käyhty (National Public Health Institute, Helsinki, 
Finland).  Microtitre plates were coated with 100 µl of either toxoid at a concentration 
of 0.125 µg/ml (tetanus) or 0.25 µg/ml (diphtheria) in a 0.05 mol/l carbonate buffer, pH 
9.6, and incubated overnight at 8°C.  In the morning, these plates were washed with 
0.05% Tween-PBS®, and blocking was done with 100 µl of 1% human serum albumin 
(Finnish Red Cross Blood Services, Helsinki, Finland) in PBS for one hour at room 
temperature. Sera were diluted in 0.2% human serum albumin in 0.05% Tween-PBS® to 
a concentration of 1:400 for tetanus-coated plates and 1:200 for diphteria-coated plates.  
Samples of 100 µl were applied to washed microtitre plates in duplicate and incubated 
for 2 hours at room temperature. After washing, 100 µl of alkaline phosphatase-
conjugated anti-human rabbit IgG (Jackson Immuno Research) was added in a dilution 
1:3000 in 0.05% Tween-PBS® with 0.2% human serum albumin.  After incubation for 
90 minutes at room temperature and washing, 100 µl of phosphatase substrate (p-
nitrophenyl disodium phosphate, Sigma) diluted in 0.05 mol/l carbonate and 0.001 mol/l 
MgCl2•6 H2O buffer, pH 9.6 (1 tablet/5 ml), was added. Microtitre plates were then 
incubated at room temperature for 30 minutes. The end-product was measured at 405 nm 
in a semi-automatic photometer (Titertek Multiscan).  
The standard was diphuman immunoglobulin, another gift from Dr. Helena Käyhty. 
It contained 65 IU/ml of tetanus antibodies and 201 IU/ml of diphtheria antibodies. The 
standard is annually calibrated at the National Health Institute with the World Health 
Organization’s International Standard of Tetanus Human Immunoglobulin and the 
International Standard of Diphtheria Equine Antitoxin. 
A blood sample was given by all 72 children of the preterm group (100%) and by 
64 of the 65 children of the full-term group (98%). In analysis of food antibodies, the 
volume of the blood sample was sufficient for 62 in the preterm group (86 %) and for 
61 in the term group (94%).   
Spirometry testing (II) 
Flow-volume spirometry testing with  a spirometer (Vitalograph Compact Spirometer 
Ltd., UK) was performed at rest and 10 minutes after an exercise challenge. At the 
testing, the children were sitting and wearing nose clips. Criteria for acceptance of the 
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recording were based on the guidelines of the American Thoracic Society (1994). 
During the exercise, which consisted of jumping on the trampoline for 6-8 minutes, the 
arterial pulse was monitored by a pulse meter (Polar Accurex, Finland), and the 
arterial oxygen saturation by a pulse oxymeter (Nellcor N-20, USA). The objective of 
the exercise was to produce breathlessness and a heart rate exceeding 170 beats per 
minutes for a 6-minute period. The following spirometry values were analysed: forced 
vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/ FVC 
ratio, forced expiratory flow after 50% of vital capacity has been exhaled (FEF50) and 
forced mid-expiratory flow of FVC (FEF25-75). The results were expressed and 
analysed as percentages of the predicted values adjusted for the age, sex and height of 
the child (Knudson et al. 1983). 
Before the visit to the outpatient clinic, 16 of the 72 children in the preterm group 
(22%) and 5 of the 65 children in the full-term group (8%) had had a recent respiratory 
infection and thus were excluded from spirometry testing. Of the reminder, 6 in the 
preterm group (11%) and 6 in the full-term group (10%) were unable to perform 
spirometry acceptably according to the established criteria. Thus, spirometry testing was 
performed on a total of 50 children born preterm (69%) and 54 children born full-term 
(83%). 
Statistical methods 
Comparisons of categorical variables between the groups (environmental background 
factors, respiratory and atopic symptoms) were examined by Pearson´s chi-squared test 
or by Fisher´s exact test (I, II, III, IV). The following cut-point values were used to 
categorize some variables as dichotomous:   
• 27 weeks’ gestational age (II) or 30 weeks’ gestational age (III) 
• serum total IgE 320 kU/l (I, II, III) 
• allergen-specific IgE antibodies 0.8 kU/l (I, II, III) 
• serum ECP 15 ug/l  (II) 
• introduction of cow’s milk-based formula before 50 days after birth (III) 
• morbidity due to frequent respiratory infection (more than 6 episodes in 6 
months) (I, II) 
• more than one sibling (I, II) 
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of about 1.6. Thus, with a ratio of 1.5 between preterm and full-term babies, 349 
preterm and 524 full-term babies were calculated to be needed to detect a risk ratio of 
1.4 at a 5% level of significance and with 80% power.  
The groups were unpaired. Test results were interpreted as statistically significant 
when the p-value was 0.05 or less. P-values ≤0.1 were indicated in the tables. P-values 
throughout the study were calculated as two-sided. Statistical analyses were done with 
SPSS Release 8.0 for Windows. 
ETHICAL CONSIDERATIONS 
The study was approved by the Ethics Committee of the Hospital for Children and 
Adolescents, University of Helsinki, and by the municipal authorities of the educational 
system of Helsinki and Kirkkonummi. Written consent was obtained from all families 
participating in the study. 
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RESULTS 
ATOPY IN CHILDREN BORN PRETERM (I) 
Atopic findings  
The frequency of atopy was significantly lower in the preterm than in the full-term 
group; atopic symptoms were found in 31% of preterms versus 49% of full-terms (OR 
0.45, 95% CI 0.23-0.91, p=0.026), and obvious atopy was observed in 15% of preterms 
and 31% of full-terms (OR 0.41, 95% CI 0.18-0.93, p=0.030). Frequencies of atopic 
eczema and allergic rhinoconjunctivitis separately analysed were also lower in the 
preterm than in the full-term group, but these differences did not reach statistical 
significance. Atopic asthma was equally common in both groups, whereas asthma 
without emphasis on atopy was more common in the preterm group (17% versus 8%, 
p=0.11) (Table 5). 
 
 
Table 5. Proportions of cumulative incidences of respiratory and atopic symptoms (%) in the two groups 
and differences between the groups.  
 
 Preterm group  Full-term group  p-value * OR † 95% CI 
 (n=72) (n=65)  
Atopic eczema, % 22 35 0.088 0.52 0.25-1.11 
Allergic rhinoconjunctivitis, % 19 34 0.056 0.47 0.22-1.03 
Asthma, % 17 8 NS  2.40 0.80-7.23 
Atopic asthma ‡, % 6 6 NS 0.89 0.21-3.74 
Atopy §, % 31 49 0.026 0.45 0.23-0.91 
Obvious atopy ||, % 15 31 0.030 0.41 0.18-0.93 
Recurrent wheezing ¶, % 43 17 0.001 3.71 1.67-8.25 
Wheezing during the past year, % 12 12 NS  1.02 0.37-2.82 
* Chi-squared test. 
† Logistic regression method. 
‡ Asthma with serum total IgE over 320 kU/l, at least one allergen-specific IgE level over 0.8 kU/l, or at least one positive skin 
prick test reaction. 
§ Atopic eczema, allergic rhinoconjunctivitis, and/or atopic asthma (atopic symptoms in at least one organ). 
|| Atopic symptoms in at least one organ and serum total IgE over 320 kU/l, at least one allergen-specific IgE level over 0.8 kU/l, or 
at least one positive skin prick test reaction. 
¶ Three or more episodes of wheezing. 
NS = non-significant 
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In SPT, the children born full-term had two or three times more positive reactions 
to the tested allergens (Table 6). Comparing the frequencies of one, two and three 
positive SPT reactions to the nine allergens in the panel, significant differences in all 
categories were seen between the groups (p=0.007, p=0.045 and p=0.010, respectively). 
The same trend was observed when positivity for serum allergen-specific IgE antibodies 
was analysed (Table 6). The geometric mean of serum total IgE was significantly higher 
in the full-term group, 74.3 kU/l (95% CI 51.5-107.2) versus 40.7 kU/l (95% CI 28.9-
57.4) (p=0.020). A corresponding trend was seen in serum ECP levels, 8.9 µg/l (95% CI 
7.1-11.0) versus 6.8 µg/l (95% CI 5.7-8.1) (p=0.065). 
 
 
Table 6. Proportions of children (%) in the groups with positive SPT reactions to nine standard test 
solutions, and children with high serum allergen-specific IgE levels (>0.8 kU/l), and the differences 
between the groups. 
 
Positive SPT Preterm group Full-term group p-value * 
 (n=72) (n=65)  
Birch, % 10 23 0.034 
Timothy, % 8 20 0.069 
Meadow fescue, % 11 26 0.023 
Mugwort, % 3 9 NS 
Cat, % 6 17 0.033 
Dog, % 3 11 0.059 
Dermatophagoides pteronyssinus, % 1 3 NS 
Latex, % 1 0 NS 
Egg, % 0 0 NS 
At least 1 positive reaction, % 17 37 0.007 
At least 2 positive reactions, % 14 28 0.045 
At least 3 positive reactions, % 6 20 0.010 
Serum-specific IgE  Preterm group Full-term group p-value *  
measurement >0.8 kU/l (n=72) (n=64)  
Birch, % 11 20 NS  
Cat, % 4 11 NS 
Egg, % 0 3 NS 
At least 1 of the above 3  
measurements >0.8 kU/l, % 12 23 0.095 
* Chi-squared test. 
SPT = skin prick test. 
NS = non-significant 
 
 
The inverse association between prematurity and atopy remained significant when 
adjusted in multivariate analysis for parental atopy, smoking of parents, infection 
morbidity of the child, presence of furred pets at home and sex of the child. In the 
model, prematurity was associated with a decreased risk of obvious atopy (OR 0.42, 
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95% CI 0.18-0.98, p=0.046). Of the other variables in the model, only family history of 
atopy was significantly associated with atopy, increasing the risk (OR 2.74, 95% CI 
1.06-7.08, p=0.037). The inverse association between prematurity and SPT-positivity 
was also seen in multivariate analyses (OR 0.34, 95% CI 0.15-0.76, p=0.008). Thus, the 
difference in the frequency of atopy between the groups could not be explained by 
possible confounding factors or by differences in any background factors. 
Factors associated with atopy  
The association of background factors (sex, respiratory infection morbidity during the 
first two years of life, parental atopy, educational level of parents, number of children in 
the family, furred pets at home, smoking of parents, type of home locality) with atopy 
was analysed for both groups. The only factor significantly associated with atopy in 
both groups was parental atopy (in the preterm group, OR 3.68, 95% CI 1.23-10.99, 
p=0.020; in the full-term group, OR 13.11, 95% CI 3.32-51.81, p=0.0002). Parental 
smoking during the first year of the child´s life was related to an increased risk of atopy 
in the full-term group (OR 3.28, 95% CI 1.11-9.70, p=0.032).  
Parental smoking remained a significant risk factor of atopy in children born at 
term when analysed by the multivariate method (adjusted OR 14.1, 95% CI 1.5-132, 
p=0.02), as did parental atopy in both groups (preterm group, OR 3.62, 95% CI 1.2-
10.9, p=0.02; full-term group, OR 46.0, 95% CI 4.8-441.4, p<0.001). The analyses were 
adjusted for all background variables, which were also analysed separately by univariate 
methods. 
Perinatal and neonatal events and treatments during the intensive care period were 
investigated thoroughly in the preterm group, in the univariate analyses no single factor 
was found to be significantly associated with symptomatic or obvious atopy.  The 
variables used in the analyses were gestational age; cause of preterm delivery; mode of 
delivery; duration of mechanical ventilation and oxygen therapy; RDS, BPD, blood 
culture-verified sepsis; feeding with cow´s milk-based formula or protein fortifier 
before 2 weeks of age; and length of hospital stay. 
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ATOPY IN RELATION TO RESPIRATORY SEQUELAE IN 
CHILDREN BORN PRETERM (II) 
Wheezing, asthma and atopy  
Cumulative incidence of wheezing was significantly higher in the group of children 
born preterm than in the group of children born full-term, 43% versus 17% (OR 3.71, 
95% CI 1.67-8.25, p=0.001), but the frequency of wheezing during the past year was 
equally common in both groups, 12% (Table 5). Thus, in the preterm group, wheezing 
significantly improved with age; only 26% (8/31) of these wheezers still wheezed (plus 
one new case), whereas in the full-term group, 73% (8/11) of wheezers still wheezed 
(p=0.011). 
In the preterm group, cumulative incidence of wheezing (but not asthma) was 
significantly associated with low gestational age, RDS, BPD and oxygen 
supplementation at the gestational age of 36 weeks (p=0.039, p<0.001, p<0.001 and 
p=0.002, respectively), but not with intrauterine growth retardation, parenteral 
dexamethasone or surfactant treatment. 
The association of atopy with cumulative incidence of wheezing was significantly 
different between the groups according to several indicators of atopy. More than 60% of 
wheezers in the full-term group had had some atopic findings; the corresponding 
proportion in the preterm group was only 20-30%. Wheezers in the full-term group also 
had a positive family history of atopy significantly more often than wheezers in the 
preterm group (Table 7).  
Table 7. Proportions of children (%) in the non-wheezer and wheezer subgroups. Difference in the frequency of atopic findings between non-wheezers and wheezers 
within the groups, and between wheezers of the two main groups. 
 
   
 Preterm group (n=72)  Full-term group (n=65)   
       Difference between 
 Non-wheezers Wheezers  Non-wheezers Wheezers  wheezers of the two groups 
 (n=41) (n=31) p-value * (n=54) (n=11) p-value * p-value  
  
 
Asthma, % 5 32  0.002 0 46  <0.001 NS  
Allergic rhinoconjunctivitis, % 12 29 NS 24 82  0.001 0.004  
Obvious atopy, % 10 23 NS 24 64  0.026 0.024  
Prick test positive, % 12 † 23 NS 32 † 64  NS 0.024  
Specific S-IgE(s) >0.8 kU/l, % 7 19 NS 17 60  0.008 0.040  
S-ECP >15 µg/l, % 17 13 NS 18 50 0.046 0.025  
Parental asthma, % 7 6 NS 2 9 NS NS  
Parental atopy, % 51 52 NS 61 91 NS 0.030 
  
 
* Difference between non-wheezers and wheezers within the main group. 
† Difference between non-wheezers of the two main groups also significant, p=0.027. 
NS = non-significant
Within the preterm group, no significant difference existed in the frequencies of 
atopic findings listed in Table 7 between wheezers and non-wheezers, whereas in the 
full-term group wheezing was significantly associated with allergic rhinoconjunctivitis, 
obvious atopy, high serum-specific IgE value and high serum ECP value.  
In the preterm group, wheezing was related to respiratory infections more often 
than in the full-term group, 94% versus 64% (OR 8.28, 95% CI 1.25-54.7, p=0.032), but 
less frequently to pollen season (19% vs. 54%, OR 0.20, 95% CI 0.05-0.88, p=0.049) or 
to animal contact (3% vs. 36%, OR 0.06, 95% CI 0.01-0.61, p=0.013). Exercise was 
reported to have caused wheezing equally often in both groups, in 42% of the wheezers 
in the preterm group and in 46% of the wheezers in the full-term group. No significant 
association was found in either group between wheezing and exposure to tobacco 
smoke or to furred pets in the home. 
Of those who had wheezed during the past year, in both groups atopic individuals 
comprised the majority. Within the full-term group, 75% of those who still wheezed in 
the past year had obvious atopy in comparison with 33% of those who no longer 
wheezed (p=0.49). In the preterm group, the corresponding figures were 62% and 9% 
(p=0.006). None of the neonatal factors was significantly associated with persistence of 
wheezing at 10 years of age. 
Lung function and atopy  
In spirometry testing, the preterm children at rest exhaled significantly lower values in 
all of the measured variables (Table 8). During the exercise challenge two children, both 
from the preterm group, developed manifest wheezing and one of these children also 
had major changes in lung function values measured after the exercise. However, the 
overall changes in FEV1, FEF50 and FEF25-75 postexercise did not differ significantly 
between the groups (Table 8). Nor did the mean arterial pulse or the arterial oxygen 
saturation differ between the groups during exercise.  
In the preterm group, history of wheezing was significantly associated with lower 
values of FEV1 and FEF50 (p≤0.001). Low gestational age, RDS, BPD and oxygen 
supplementation at the gestational age of 36 weeks were significantly related to lower 
values of FEV1, FEF50 and FEF25-75 (p≤0.01). Atopic children in the preterm group 
showed a trend towards lower lung function values than non-atopic children, but the 
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difference was not significant. In the full-term group, neither respiratory symptoms nor 
atopy were associated with spirometry values. Parental atopy, asthma and smoking were 
not significantly related to lung function in either group. 
 
 
Table 8. Spirometry results and differences between groups. 
 
 Preterm group Full-term group 
 (n=50) (n=54)  
FVC, % of predicted ±SD 96 ±12.6 102 ±9.6 *  
FEV1, % of predicted ±SD 92 ±13.1 104 ±8.0 †  
FEV1/FVC, % ±SD 84 ±7.8 88 ±5.4 †  
FEF50, % of predicted ±SD 82 ±21.6 106 ±20.7 † 
FEF25-75, % of predicted ±SD 87 ±24.0 114 ±21.2 †  
FEV1 change, % after exercise ±SD  -1.5 ±10.2 -0.8 ±3.1 
FEF50 change, % after exercise ±SD -4.3 ±15.1 -1.6 ±10.1 
FEF25-75 change, % after exercise ±SD -1.3 ±16.3 -3.4 ±11.5  
* p=0.016 by t-test. 
† p≤0.001 by t-test. 
FVC = forced vital capacity, FEV1 = forced expiratory volume in one second, FEF50 = forced expiratory flow after 50% of vital 
capacity has been exhaled, FEF25-75 = forced mid-expiratory flow  of FVC. 
 
ANTIBODY LEVELS TO EARLY-INTRODUCED FOOD 
ANTIGENS IN CHILDREN BORN PRETERM (III)  
IgG and IgA antibody levels  
Children in the preterm group were found to have significantly lower levels of IgG 
isotype antibodies to whole cow’s milk and ACAS, with geometric mean levels being 
about one-fourth of those in the term group (Table 9). Measurable IgG levels to BLG 
were significantly less frequent in the preterm group than in the term group. IgA 
antibodies to whole cow’s milk and ACAS were also lower in the preterm group, 
whereas the proportions of children with measurable levels of IgA antibodies to BLG 
showed no difference between the groups.  IgG antigliadin levels were lower in the 
preterm group, and the same tendency was observed for IgG ovalbumin antibodies 
(Table 9).  
The preterm and term groups had similar geometric mean levels of IgG antibodies 
to tetanus  (55.7 IU/ml x10-3 with 95% CI 54.1-57.4 IU/mlx10-3 and 45.3 IU/mlx10-3 
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with 95% CI 33.4-61.5 IU/mlx10-3, respectively) and diphtheria toxoids (20.0 
IU/mlx10-3 with 95% CI 15.4-26.1  IU/mlx10-3 and 16.7 IU/mlx10-3 with 95% CI 12.9-
21.7 IU/mlx10-3, respectively). 
Factors associated with antibody levels 
Within the preterm group, gestational age was associated with cow’s milk antibody 
levels:  those born before week 30 had significantly lower levels of IgA cow’s milk 
antibodies, and the proportion with positive IgG isotype antibodies to BLG among these 
patients was lower than among those born between 30 and 34 gestational weeks (Table 
9).  
Those children in the preterm group who had consumed cow’s milk formula 
before age 50 days had significantly lower levels of IgA antibodies to cow’s milk and 
ACAS than did those started on formula after day 50 (Table 9).  
The children in the preterm group with obvious atopy had significantly lower 
levels of cow’s milk IgG antibodies (0.7 AU with 95% CI 0.2-2.8 vs. 3.6 AU with 95% 
CI 2.5-5.3, p=0.04) and ACAS IgG antibodies (0.2 AU with 95% CI 0.1-0.4 vs. 0.8 AU 
with 95% CI 0.5-1.3, p=0.02) than did those without atopic symptoms. They did, 
however, show higher levels of ovalbumin IgG antibodies than did children without 
atopic symptoms (162 AU with 95% CI 114-230 vs. 36 AU with 95% CI 22-61, 
p<0.001). In the term group, no difference was apparent between children with obvious 
atopy and those with no symptoms of atopy.  
Logistic regression analyses showed a significant OR for preterm children with 
atopic symptoms being in the lowest quartile for IgG cow’s milk antibodies (OR 11.9, 
95% CI 1.6-88, p=0.002). Significant ORs for being in the lowest quartile of IgA cow’s 
milk antibodies were related to early introduction of cow’s milk formula (before day 50; 
OR 13, 95% CI 1.2-144, p=0.04) and gestational age of less than 30 weeks (OR 11, 
95% CI 1.1-120, p=0.04).  
Table 9.  Geometric mean levels with 95% confidence intervals (CI) of IgA and IgG antibodies to cow’s milk and  α-casein, of IgG antibodies to gliadin and ovalbumin in 
arbitrary units (AU) and the proportion of positive IgA and IgG titres to β-lactoglobulin (BLG) in 10-year-old children who were born preterm or full-term. 
 
Preterm group  Full-term 
group  
(n=61) 
Preterm 
group 
(n=62) 
p-value 
Born before 
gestational  
week 30 (n=40) 
Born after 
gestational   
week 30 (n=22)
p-value Milk-based formula 
before age 50 days 
(n=36) 
Milk-based formula 
after age 50 days 
(n=24) 
p-value 
Cow’s milk IgA  (AU), Mean 
(95% CI) 
1.0   
(0.7-1.5) 
0.3  
(0.2-0.5) 
< 0.001* 0.2  
(0.1-0.4) 
0.6  
(0.3-1.5) 
0.03* 0.2 
(0.1-0.4) 
0.5 
(0.3-1.0) 
0.03* 
 
Cow´s milk IgG (AU), Mean 
(95% CI) 
9.2   
(7.0-12.0) 
2.4   
(1.6-3.6) 
< 0.001* 2.0  
(1.3-3.2) 
3.3  
(1.5-7.3) 
0.08* 1.7 
(1.0-3.1) 
3.2 
(1.8-3.2) 
NS* 
α-casein IgA (AU), Mean 
(95% CI) 
2.0 
(1.3-3.1) 
0.5  
(0.3-0.8) 
< 0.001* 0.4  
(0.2-0.6) 
0.9  
(0.4-2.1) 
0.09* 0.3 
(0.2-0.6) 
0.8 
(0.4-0.8) 
0.04* 
 
α-casein IgG (AU), Mean 
(95% CI) 
2.4   
(1.8-3.3) 
0.48  
(0.3-0.8) 
< 0.001* 0.4 
(0.2-0.7) 
0.7 
(0.3-1.9) 
NS* 0.3 
(0.2-0.6) 
0.8 
(0.4-1.6) 
NS* 
BLG IgA, proportion  
with positive titre (%) 
57 
 
45 
 
NS† 45 
 
48 
 
NS† 40 
 
54 
 
NS† 
BLG IgG, proportion 
with positive titre (%) 
90 
 
59 
 
<0.001† 50 
 
76 
 
0.05† 54 
 
67 
 
NS† 
Gliadin IgG (AU), Mean 
(95% CI) 
3.2 
(2.3-4.6) 
1.7 
(1.1-1.7) 
0.03* 1.4 
(0.8-2.5) 
2.4 
(1.1-5.3) 
NS*    
Ovalbumin IgG (AU), Mean 
(95% CI) 
74 
(53-103) 
48 
(32-71) 
0.1* 46 
(27-80) 
49 
(28-85) 
NS*    
 
* By  t-test.    
†
  By Chi-squared test. 
NS = non-significant.
MATERNAL ATOPY AND PRETERM BIRTH (IV) 
Mothers of VLBW infants reported having less atopic symptoms and less doctor-
diagnosed atopic diseases than mothers of infants born at term (Table 10). Among 
mothers of ELBW infants, a significant correlation was present between the infant’s 
birth weight and the number of verified atopic diseases in the mother (Spearman's 
correlation coefficient = 0.29, p=0.009). The OR for mothers of ELBW infants showed 
a significantly decreased risk of having doctor-diagnosed allergic rhinitis (OR 0.49, 
95% CI 0.26-0.89) (Table 11).   
 
 
Table 10. Allergic symptoms and doctor-diagnosed allergies in mothers and fathers of preterm infants of 
very low birth weight (<1500 g, VLBW) and of full-term infants. Infants of birth weight (BW) below 
1000 g (extremely low birth weight, ELBW)  and between 1000 and 1500 g are analysed separately.  
 
Type of allergy  ELBW infants  
<1000 g 
Infants with BW 
1000-1500 g 
All VLBW infants 
<1500 g 
Full-term infants 
>3000 g 
Mothers ( n=76) (n=94) (n=170) (n=306) 
History of allergic rhinitis, % 45 51 48 55 
Diagnosed allergic rhinitis, % 20 32 27 34 
History of asthma, % 15 17 16 19 
Diagnosed asthma, % 12 14 13 15 
History of atopic dermatitis, % 29 41 36 39 
Diagnosed atopic dermatitis, % 24 33 29 33 
Fathers  (n=76)  (n=89)  (n=165)  (n=301) 
History of allergic rhinitis, % 42 45 44 46 
Diagnosed allergic rhinitis, % 26 21 24 27 
History of asthma, % 17 16 16 18 
Diagnosed asthma, % 16 10 13 14 
History of atopic dermatitis, % 30 28 29 31 
Diagnosed atopic dermatitis, % 25 22 23 23 
 
When analysed with a trend test, the probability of doctor-diagnosed allergic 
rhinitis in the mother was significantly higher when the infant’s birth weight was greater 
(p=0.03).  A similar trend was also observed for self-reported symptoms of allergic 
rhinitis (p=0.1). No such differences were evident for atopic symptoms and doctor-
diagnosed atopic diseases in the fathers of the same infants (Table 11). 
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Table 11. Unadjusted odds ratios (OR) and 95% confidence intervals (CI) showing the risk of parental 
atopy on preterm birth, and p-value of the test for trend. 
 
   Mothers   Fathers  
  % OR 95% CI % OR 95% CI 
History of allergic 
rhinitis 
BW <1000 g 45 0.66 0.40-1.09 42 0.85 0.51-1.42 
 BW 1000-1500 g 51 0.85 0.53-1.35 45 0.96 0.60-1.54 
 
 Full-term  55 1  46 1  
 
 Test for trend  
(p-value) 
 0.1   0.55  
Doctor-diagnosed 
allergic rhinitis 
BW <1000 g 20 0.49 0.26-0.89 26 0.95 0.54-1.69 
 BW 1000-1500 g 32 0.92 0.56-1.51 21 0.73 0.41-1.28 
 
 Full-term  34 1  27 1  
 
 Test for trend  
(p-value) 
 0.03   0.62  
History of asthma BW <1000 g 15 0.74 0.37-1.49 17 0.97 0.50-1.88 
 
 BW 1000-1500 g 17 0.91  16 0.87  
0.46-1.66 
 Full-term  19 1  18 1  
 
 Test for trend  
(p-value) 
 0.40   0.82  
Doctor-diagnosed 
asthma 
BW <1000 g 12 0.78 0.36-1.67 16  
 
0.59-2.39 
 
BW 1000-1500 g 14 0.94 0.48-1.84 10  
 
0.33-1.53 
 
Full-term  15 1  14 1 
 
 
 
Test for trend  
(p-value) 
 0.54   0.87  
History of atopic 
dermatitis 
BW <1000 g 29 0.63 0.37-1.09 30  0.56-1.66 
 BW 1000-1500 g 41 1.07 0.67-1.71 28  
 
0.51-1.46 
 Full-term  39 1  31 1 
 
 
 Test for trend  
(p-value) 
 0.17   0.76  
Doctor-diagnosed  
atopic dermatitis 
BW <1000 g 24 0.64 0.36-1.15 25 1.11 0.62-1.99 
 
BW 1000-1500 g 33 1.00 0.61-1.65 22 0.93 
 
0.52-1.66 
 Full-term  33 1  23 1 
 
 
 Test for trend  
(p-value) 
 0.19   0.81  
BW = birth weight 
DISCUSSION 
ATOPIC IMMUNE RESPONSES IN CHILDREN BORN 
PRETERM  
Atopy and prematurity 
The main outcome of the study was that children born preterm bore a decreased risk of 
atopic sensitization; cumulative incidence of symptomatic atopy was significantly lower 
in the group of prematurely born children than in the group of children born at term. It 
is noteworthy that the frequency of each atopic symptom separately analysed also 
reflected the same tendency of lower incidence in the preterm group, although these 
differences did not reach the pre-defined level of statistical significance. Parallel results 
in all IgE-related measurements in the study (number of positive SPT reactions, serum 
total IgE and ECP levels) strengthened the validity of the outcome.  
Frequencies of atopic diseases recorded here in the full-term group are consistent 
with the recent results of population-based epidemiological studies, in which the 
lifetime prevalence of allergic disorders and their regional differences in Finnish 
paediatric populations were evaluated (Pekkanen et al. 1997, Remes et al. 1998). 
According to these studies, of 11 607 children aged 13-14 years, 44% had had at least 
one atopic disorder; in the Helsinki area, the corresponding figure was 48%. The 
lifetime prevalence of self-reported asthma was 4-8%, allergic rhinitis 44-55% and 
itching dermatitis 24-28% (the ranges are related to the different geographical regions 
where the study was carried out). In our full-term group, the corresponding figures were 
49%, 8%, 34% and 35%, the frequency of allergic rhinitis being slightly lower and the 
frequency of atopic eczema slightly higher than in the population-based study. 
Previous studies evaluating the relation between prematurity and atopy have 
yielded inconsistent results. A group of earlier studies, listed in Table 1a, describe 
findings in complete contradiction to ours. These studies have reported a positive 
association between prematurity or low birth weight and different variables of atopy, 
leading to the assumption that prematurely born children are at risk for contracting 
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atopic diseases. These results can be interpreted as suggesting that immaturity of 
immune responses and increased permeability of the gut during early antigen exposure 
leads to sensitization rather than development of tolerance, as shown in rodent studies 
of tolerance (Strobel and Ferguson 1984, Miller et al. 1994). 
The general view of the consequences of early life exposure has during recent 
years evolved, and antigen exposure during the neonatal period is currently thought to 
be a tolerogenic rather than an immunogenic event. Consequently, preterm children who 
are immaturely exposed to the extra-uterine environment, can be hypothesized to have a 
decreased risk of atopic diseases. Our findings support this hypothesis and are in 
agreement with several other recent studies presented in Table 1c. The inverse 
association between prematurity and atopy was first noted by David and Ewing (1988) 
as a lower number of children born preterm among patients suffering from severe atopic 
eczema. Ten years later in Sweden, Bråbäck and Hedberg (1998) performed an 
epidemiological study by linking the perinatal and atopic data from two registers of 149 
398 male conscripts. They found that both gestational age of less than 33 weeks (OR 
0.75, 95% CI 0.61-0.91, p=0.0001) and VLBW (OR 0.69, 95% CI 0.49-0.97, p<0.0001) 
were significantly related to a reduced risk of allergic rhinitis. The study included large 
numbers of subjects with VLBW (<1500 g, n=362) and subjects born very prematurely 
(<33 gestational weeks, n=1269), suggesting a high validity for the outcome. They 
speculated that there might be less pronounced foetoplacental Th2 cell skewing in 
pregnancies that terminate prematurely, and thus, babies born of these pregnancies 
could have a more Th1 cell-deviated immune balance. 
A recent study from Sweden (Mai et al. 2003) had a research protocol closely 
resembling that of the present study, including similar aims, inclusion criteria, size of 
the cohorts, year of birth and age of the children and evaluation methods. The authors 
also measured the secretion of IL-4, IL-5 and IFN-γ by PBMCs. Despite the congruence 
of the research protocols, results in that study were different from ours: they found no 
significant association between VLBW and markers of atopy. Only asthma was reported 
to be more frequent in VLBW children. Martino et al. (1989) also performed a similar 
research in Italy, but in that study the children were younger and their state of 
immaturity was less pronounced. Neither this study nor the epidemiological studies 
described in Table 1b describe any significant association between frequencies of atopic 
findings and gestational age or birth weight. These results lead to the assumption of an 
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equal functional capacity to develop tolerance or sensitization irrespective of 
immunological maturity stage during the neonatal period. 
Direct comparisons of our results and those of previous studies evaluating the 
association between prematurity or low birth weight and atopy are hampered by the lack 
of uniformity in study protocols. Differences in subjects, methods and outcome 
variables are often considerable and must be taken into account. One special problem 
complicating comparison relates to the variables of low birth weight and low gestational 
age. While these variables often widely overlap, they may also reflect different 
developmental aspects and have different consequences. Low birth weight is related to 
prematurity but may also reflect intrauterine growth retardation. Infants of low 
gestational age, on the other hand, may have a birth weight either appropriate or low 
(only rarely high) for gestational age. 
Atopy and long-term respiratory sequelae 
We demonstrated a significant difference in the background factors of wheezing and 
asthma between children born preterm and those born at term. Within the full-term 
group, over half of the wheezers had had some atopic manifestations and over 90% had 
a positive family history of atopy (Table 7), whereas in the preterm group the 
cumulative incidence of wheezing had no significant association with any atopic finding 
or with parental atopy. The difference between the groups was also reflected in the 
factors causing wheezing: wheezers in the full-term group had symptoms significantly 
more frequently in relation to typical allergen contacts, such as exposure to pollen and 
animals, whereas symptoms in wheezers in the preterm group were more often related 
to respiratory infections. 
The role of atopy in wheezing of children born preterm compared with children 
born full-term has not been previously evaluated. In some studies focusing on 
respiratory morbidity in preterm children, the frequency of atopy was reported, but was 
not compared with the corresponding frequency in controls (Chan et al. 1989a, 
Pelkonen et al. 1997). These studies found no significant association between 
respiratory symptoms and SPT reactions in the groups of preterm children. In the study 
of late pulmonary sequelae of BPD, Northway et al. (1990) analysed the frequency of 
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atopy between groups of preterm children and controls but did not link the result to 
respiratory findings. 
The significant association found here between atopy, asthma and wheezing in the 
full-term group is in agreement with the results of several previous studies in which 
unselected populations of older children and young adults were evaluated (Burrows et 
al. 1989, Sears et al. 1991, Peat et al. 1996, Strachan et al. 1996). In infants, however, as 
Martinez et al. (1995) have demonstrated, a considerable proportion of wheezing is non-
atopic and transient, is related to a diminished airway function at birth and becomes 
symptomatic especially during viral infections. Wheezing in prematurely born children 
can be considered to be more parallel to this type of wheezing. The following findings 
support this argument:  
1.  Children of the preterm group significantly more frequently had recurrent 
wheezing especially in relation to respiratory infections.  
2.  The cumulative incidence of wheezing in the preterm group was not 
associated with atopy. 
3.  Wheezing in the prematurely born children was transient. These children 
tended to recover, as also demonstrated in a few earlier studies (Kitchen et al. 1992, 
Blaney et al. 2001). The prevalence of current wheezing was only 12% in the group of 
preterm children, being the same in the full-term group. 
An increased risk of long-term pulmonary sequelae in children born preterm has 
also been shown in several previous studies (Kitchen et al. 1992, Rona et al. 1993, Elder 
et al. 1996, McLeod et al. 1996, Gross et al. 1998). Prematurity and low birth weight 
have therefore been widely considered significant risk factors for childhood wheezing 
and asthma (Seidman et al. 1991, Arshad et al. 1993, Frischer et al. 1993, von Mutius et 
al. 1993, Shaheen et al. 1999, Katz et al. 2003, Mai et al. 2003), although the opposite 
conclusion has also been reached (Sears et al. 1996, Fergusson et al. 1997, Gregory et 
al. 1999, Leadbitter et al. 1999, Räsänen et al. 2000, Sin et al. 2004). 
In the preterm group, several intrinsically correlated neonatal variables relating to 
severe immaturity (low gestational age, RDS, BPD, oxygen supplementation at the 
gestational age of 36 weeks) were significantly associated with the cumulative 
incidence of wheezing but not with current wheezing. The only prognostic factor for 
current wheezing in children born preterm was atopic predisposition, similar to in 
children born full-term. This finding suggests that those in the preterm group who 
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wheezed at the age of 10 years belong to a different subgroup of wheezing than the 
majority of the preterm wheezers. The retrospective approach of this study, 
unfortunately, did not allow for analysis of age at onset of wheezing. 
Prematurely born children exhaled significantly lower spirometry values in all 
measured parameters. The means of these values in both groups were within normal 
limits, but as SD values and the significant difference between the groups reflect, 
children of the preterm group more frequently exhaled results classified as abnormal 
(e.g. with regard to FEV1 value, 16 children of the preterm group exhaled a result of 
less than 80% of the expected, whereas in the full-term group only 1 child did).  
Impaired lung function in children born preterm has also been reported in many 
previous studies (Bertrand et al. 1985, Chan et al. 1989b, Northway et al. 1990, von 
Mutius 1993, Rona et al. 1993, McLeod et al. 1996, Pelkonen et al. 1997, Kennedy et 
al. 2000). These results indicate obstructed airways and possibly reduced total lung 
capacity or air-trapping. In the preterm group, wheezing, asthma and several neonatal 
factors that were correlated with the frequency of wheezing were also associated with 
impaired lung function, as also shown in earlier reports (Chan et al. 1989b, von Mutius 
et al. 1993, Parat et al. 1995, McLeod et al. 1996, Pelkonen et al. 1997, Kennedy et al. 
2000). Neither atopic predisposition of a child nor parental atopy, asthma or smoking 
was significantly associated with lung function in either group. However, the low 
number of subjects completing spirometry testing may have prevented the detection of 
weak associations. 
In the exercise challenge test, no significant differences were present between the 
groups. This corresponds with the finding of similar histories of exercise-induced 
wheezing in the groups, but disagrees with the results of a few previous studies which 
have demonstrated exercise-induced bronchial hyperreactivity in children born preterm 
(McLeod et al. 1996, Bader et al. 1987, Gross et al. 1998). The form of the exercise 
challenge in our study may have limited detection of changes; the exercise was 
performed by jumping on a trampoline, and spirometry blowing was performed after the 
exercise only once, at 10 minutes post-exercise.    
The data of the present study demonstrate no significant association between 
prematurity and classical atopic asthma. The result is not surprising when considered 
from the clinical viewpoint but does indicate the diversity of the background of 
wheezing conditions and brings into question the validity of direct comparisons of all 
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wheezing conditions without subgrouping. More precise nomenclature for respiratory 
problems and asthma is called for.  
Food antigen responses 
Immaturity at birth was found to have a significant effect on food antigen-induced 
immune responses, the effect still being measurable after 10 years. Children born 
preterm had markedly lower levels of IgA and IgG antibodies to cow’s milk and to its 
protein fractions. IgG gliadin antibodies were also significantly lower, but antibody 
levels to ovalbumin did not differ between the groups. The result is in agreement with 
an earlier study reporting decreased production of specific IgG and IgM antibodies to 
cow’s milk in premature infants (Helms and Rieger 1987). The children in that study 
were, however, much younger than the children in the preterm group here. The 
immaturity of the immune and intestinal systems of VLBW infants appears to result in 
suppression of immune response to oral antigens given during early life, thereby making 
the B cells of these children more tolerant to food antigens. The finding that these same 
preterm children had less atopy may be another facet of their tolerance development, 
possibly reflecting an inherent susceptibility of immature T cells to induce tolerance, as 
speculated by Takahashi et al. (1995). Results of rodent studies, however, diverge from 
this hypothesis (Strobel and Ferguson 1984, Miller et al. 1994). It is thus probable that 
maturational status is not a main determining factor in development of oral tolerance. In 
different circumstances, neonatal naive T cells irrespective of immaturity can be either 
immunized, tolerized or switched to Th1 or Th2 responses depending on the dose of the 
antigen, the condition under which it is introduced, the type of adjuvant and the type of 
APC (Ridge et al. 1996).               
The difference in antibody levels between preterm and full-term children was 
dependent on the age at introduction of the food antigen. The difference was strongest 
with early-introduced cow’s milk-based formula, less strong with later-introduced cereal 
and non-significant with egg extract, which is generally introduced much later to the 
diet. The effect of age at introduction was evident even within the preterm group; the 
earlier the cow’s milk-based formula was introduced, the lower the antibody levels. In 
previous studies of full-term children (Tainio et el. 1988, Jenmalm and Björksten 1998), 
the effect has been shown to be the opposite; when cow’s milk-based formula was 
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introduced early, titres were higher. The result of the present study may reflect the role 
of maturation of the immune system in antibody production capacity and a rapid change 
in intestinal permeability in preterm infants. 
The preterm and term children showed similar levels of IgG antibodies to tetanus 
and diphteria toxoids. This indicates that children born preterm did not have a 
generalized B cell defect. In several earlier studies, prematurely born children have been 
shown to develop adequate vaccine-induced antibody levels for protection against a 
particular infection, but the antibody levels have, however, remained significantly lower 
than in term infants (Faldella et al. 1998, Schloesser et al. 1999, Kirmani et al. 2002), 
possibly reflecting lower general antibody production capacity. 
The pathogenetic role of food antibodies in a number of food-related diseases is 
poorly understood. Aberrant immune responses to food antigens may be important in 
the development of some autoimmune diseases, such as type I diabetes (Vaarala et al. 
1999). For food allergy and atopy, IgG antibodies are widely reported to have no 
predictive value (Fälth-Magnusson et al. 1988, Tainio et al. 1988, Burks et al. 1990, 
Host et al. 1992, Barnes 1995, Keller et al. 1996). Some studies have, however, 
described an association between high IgG and IgE responses and development of 
atopic diseases (Jenmalm and Björksten 1998, Eysink et al. 1999, Oldaeus et al. 1999). 
In the preterm group here, the IgG isotype food antibodies were associated with atopy. 
In atopic preterm children, IgG antibodies to milk were lower and those to ovalbumin 
higher than in non-atopic children. This result may be related to the rapid postnatal 
decrease in intestinal absorption demonstrated previously (Kuitunen et al. 1994).  
POSSIBLE AETIOLOGICAL FACTORS EXPLAINING 
DIFFERENCES IN IMMUNE RESPONSE OF PREMATURELY 
BORN CHILDREN 
Prenatal environment 
The underlying conditions causing preterm delivery may influence immunological 
maturation of the foetus. Pre-eclampsia induces several effects on the foetus, but of 
special interest here is cortisol production because cortisol has a marked and complex 
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regulatory influence on the immune system. In pre-eclampsia, the foetus is stressed and 
the mean foetal plasma cortisol concentration is significantly higher than in normal 
pregnancies (Goland et al. 1995). In addition, glucocorticoids are also used both 
antenatally in treatment of pre-eclampsia for accelerating foetal pulmonary maturation 
and postnatally in treatment of BPD/CLD; in the preterm group here, 3% had been 
treated antenatally by steroids and 19% had been dosed with parenteral dexamethasone 
for weaning from the ventilator (Table 3). Subjects with atopic dermatitis and/or asthma 
have, by contrast, been shown to have significantly attenuated cortisol responses to 
stress (Buske-Kirschbaum et al. 2002, 2003). Together these data suggest that a higher 
concentration of plasma cortisol during the perinatal period may have a role in the 
development of Th cell balance and in subsequent atopic sensitization of preterm 
children.  
A large proportion of preterm deliveries are caused by a foetomaternal infection, 
chorioamnionitis, which may in part explain the lower frequencies of atopy in these 
children. The above-described theory related to cortisol may also be applied to perinatal 
infections, as infections cause significant stress to the foetus. However, a more up-to-
date explanation is a microbial-burden aetiology, which is based on the proven inverse 
association between infection morbidity and atopy (Shaheen et al. 1996, Matricardi et 
al. 1997, Holt et al. 1999, von Mutius et al. 2000), first presented by Strachan (1989) as 
a hygiene hypothesis. 
In this study, the causes of preterm birth included pre-eclampsia (22%), premature 
rupture of membranes (26%), chorioamnionitis (24%), multiple gestation (12%) and 
placental ablation (14%); in 25% of cases, the cause was something else or unknown. 
These conditions could exist concurrently. The aetiology of preterm delivery was, 
however, not significantly associated with atopy. This may be related to the low number 
of cases. 
Mode of delivery 
Caesarean section has been found to increase the risk of asthma of offspring in 
adulthood (Xu et al. 2001), and it has even been related to an increased risk of food 
allergy (Eggesbo et al. 2003). However, Lucas et al. (1990) reported that preterm infants 
born by Caesarean section had less wheezing and asthma. Caesarean delivery may 
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influence the infant’s immune system in several ways (Grönlund et al. 1999a), one of 
which is by changing the gut microflora; gut flora of infants born by Caesarean section 
has been shown to be disturbed for up to 6 months after birth (Grönlund et al. 1999b). 
This may have an effect on development of atopy because gut microflora is known to be 
associated with atopic sensitization (Sudo et al. 1997, Björksten et al. 2001, Kalliomäki 
et al. 2001a). 
Of the preterm children in this study, 56% were born by Caesarean section (Table 
3). If the above-mentioned positive associations between Caesarean section and asthma 
and food allergy are valid, this would increase the risk of atopy in the preterm group. It 
is, however, probable that the effect of Caesarean section on atopy is weaker than the 
effects of other environmental factors that burden preterm children. In the preterm 
group here, the mode of delivery was not associated with atopy. 
Postnatal environment  
The mean length of the hospital stay of preterm children was 3.0 months (Table 3). 
Thus, preterm infants throughout their neonatal period are exposed to a different 
environment (regimen and timetable of feeding, aero-allergen exposure, hospital 
microbial colonization) than their term-born healthy counterparts. This can be 
speculated to have a role in the conversion of Th cell balance. 
Of the preterm children, 15% had had blood-culture verified sepsis (Table 3), with 
many others likely to have experienced septicemia without laboratory confirmation. The 
frequency can be assumed to be significantly higher than among full-term infants. As 
discussed in the context of chorioamnionitis, the early infections may play a part in the 
development of sensitization. Neonatal bacterial infections of preterm infants can be 
hypothesized to affect Th cell balance by adjusting it more towards a Th1 cell-type 
profile, and thus protecting against allergen-specific Th2 cell reactions later in life.  
Use of antibiotics, on the other hand, has been shown to disturb gut flora, which 
has been speculated to prevent postnatal Th1 cell maturation (Oyama et al. 2001, 
McKeever et al. 2002). With regard to preterm infants, who are often repeatedly dosed 
with antibiotics, this could antagonize the atopy-preventing effects of infection. 
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Maternal atopy and preterm birth   
During pregnancy a Th2-deviated immune balance dominates in the maternal and 
foetoplacental immune systems, and this is considered to be fundamental for the normal 
progression of pregnancy (Wegmann et al. 1993). Th2-deviated balance also dominates 
in atopic individuals. The question therefore arises of a possible accentuating effect of 
maternal atopic status on pregnancy-related Th2 balance. Results of study IV on 
maternal atopy and preterm birth support this hypothesis; mothers of infants born at 
term had significantly more allergic rhinitis than mothers of infants born severely 
preterm. Observations of study I, which compared the family history of atopy between 
the preterm and the full-term children, are also congruent with this theory. Consistent 
findings in these two independent cohorts strengthen the conclusion.  
The finding is in agreement with the result of von Mutius et al. (1993), who 
observed that a family history of hay fever or eczema was more frequent among term 
than preterm boys (39% vs. 27%, p<0.05). However, divergent results have also been 
presented. Chan et al. (1989a) and Northway et al. (1990) found no difference in family 
history of atopy between low birth weight and reference groups. 
Nilsson et al. (1997) approached this question from an interesting viewpoint. They 
hypothesized that Th2-dominated balance in an atopic mother influences the Th2-
skewed balance of pregnancy, thereby influencing the maintenance of pregnancy. They 
evaluated this by analysing the number of children produced in relation to maternal 
atopy but did not analyse the number of preterm and term pregnancies. They found that 
atopic mothers had more children, from which they concluded that the maternal atopic 
genotype may be associated with an increased likelihood for successful pregnancy 
outcome. Sunyer et al. (2001) reached the opposite conclusion, reporting that maternal 
atopy was inversely related to the number of offspring produced.   
In some studies evaluating perinatal factors and later atopy of the child, this 
subject has been highlighted in discussion. Bråbäck et al. (1998) suggested that in 
pregnancies terminating prematurely the foetoplacental Th2 cell skewing might be less 
pronounced. This may be related to the finding that the process of labour is mediated by 
proinflammatory cytokines (IL-8, TNF-α, IL-6 and IL-1β) (Peltier 2003). 
While the association between maternal atopy and preterm birth has not been 
widely studied, the effect of maternal asthma on preterm delivery has. Maternal asthma 
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has been repeatedly linked to an increased risk of preterm delivery (Kelly et al. 1995, 
Kramer et al. 1995, Demissie et al. 1998, Liu et al. 2001, Källen et al. 2000). Kramer et 
al. (1995), however, found no association between metacholine responsiveness in the 
asthmatic mother and preterm delivery, concluding that non-atopic, non-cholinergic 
mechanisms may underlie bronchial and uterine smooth muscle lability. Some studies 
have found no relationship between maternal asthma and the course of pregnancy, 
especially when asthma is optimally controlled (Jana et al. 1995, Alexander et al. 1998, 
Minerbi-Codish et al. 1998). Asthma is, in any case, only partly attributable to atopy 
(Pearce et al. 1999). In the study of Burrows et al. (1989), 53% of adult asthma cases 
were attributable to atopy. Thus, possible associations between maternal atopy and 
maternal asthma and preterm delivery can be assumed to have different mechanisms. 
In conclusion, atopic status of the mother during pregnancy may influence the 
maintenance of a successful pregnancy, providing some protection against preterm 
delivery. This association by leading to a lower genetic risk could also partly explain the 
decreased atopic sensitization rates in preterm children. The results of multivariate 
analyses, however, showed that prematurity also has an independent effect on atopic 
predisposition of preterm children. 
METHODOLOGICAL CONSIDERATIONS  
Study subjects 
In studies I-III, the criterion for the preterm group was a birth weight of 1500 g or less. 
Thus, these subjects represented a group of VLBW children. A weight of 1500 g is 
normally reached in the Finnish population at a gestational age of 29-30 weeks (2 SD 
including weeks 28-32) (Pihkala et al. 1989). In the analyses, the mean gestational age 
of the group was found to be 28.5 (range 23.4-33.7) weeks. Thus, the group can also be 
deemed to represent a group of children born severely preterm. The designation 
“preterm” was preferred to the term “VLBW” in this study to emphasize the effect of 
immaturity rather than the effect of growth. However, with weight-based inclusion 
criteria and without adjusting weight to gestational age, children who have suffered 
from intrauterine growth retardation unavoidably become represented in the group. 
Nineteen children (26%) in the preterm group had a birth weight below -2 SD. The 
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possible effect of these children with intrauterine growth retardation on the group 
results cannot be estimated because of the relatively small group size, in addition to not 
knowing whether foetal disproportioned growth has an independent association with 
atopic sensitization. 
The criterion for the full-term control group was a birth weight of over 2500 g. 
Gestational age data for the control group were unavailable. A weight of 2500 g is 
normally reached at the gestational age of 34 weeks (2 SD including weeks 32-38) 
(Pihkala et al. 1989). Based on gestational age, the preterm and full-term groups could 
have slightly overlapped. The mean birth weight of the full-term group here was, 
however, markedly higher, 3593 (SD 470) g, with only two children having a birth 
weight of less than 2900 g. Thus, the full-term group can be assessed as representing a 
group of children born at term, although the minimum cut-off for weight could have 
been higher. 
Selection of the preterm group as 100 consecutively born children fulfilling the 
criteria was valid, but selection of the full-term group had some limitations. The 
children were invited from two Finnish-speaking schools in the Helsinki region, one 
from an urban and the other from a rural area. All children from four classes whose 
birth weight fulfilled the criterion were invited. Population-based random sampling 
from a birth cohort of the same time period and the same area as the preterm group 
would have been ideal. Congruence between our results of frequencies of atopy in the 
full-term group and results of population-based epidemiological studies on atopy in 
children shows, however, that the full-term group is representative of the general child 
population. Possible differences in background factors between the groups of preterm 
and full-term children were taken into account by performing multivariate logistic 
regression analysis related to the main outcome variables and by including possible 
confounding factors and risk factors for atopy in the model. The results of multivariate 
analysis did not change the outcome as compared with results of univariate analysis. 
In the second part of the study, the selection of the groups of parents was valid, 
but the participation was low, 56%, and this may have limited the emergence of 
differences between the groups. 
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Study design and methods 
Participation bias is always possible in a cohort study. However, the bias could be 
assumed to be similar in the preterm and full-term children, i.e. allergic individuals 
could be equally over-represented in both groups. The same argument can be applied to 
the participation of parents of preterm and full-term children. 
The study was retrospective, which set limits on the assessment of data related to 
early feeding, onset of atopic and respiratory symptoms and infection morbidity. In a 
retrospective study, the possibility of recall bias also emerges. Individuals with a 
particular adverse health outcome may be more likely to identify, remember and report 
their exposure and illness than those non-exposed. The selection criteria of the groups 
and several main outcome measures of atopy (SPT, IgEs, ECP) were, however, precise 
and out of reach of recall bias, supporting the validity of the differences found between 
the groups. 
Data collection may also be biased by an investigator who is aware of the study 
hypothesis and subjects’ exposure status. This study was not blinded; the investigators 
and nurses knew the groupings and the study hypothesis. Possible bias related to this 
issue can, nevertheless, be considered minimal because the study was performed 
according to pre-defined diagnostic criteria and by standardized methods.  
Certain limitations were, however, related to the performance of exercise 
spirometry. The exercise was performed in a non-standardized manner, by trampoline 
jumping. The objectives of the exercise were the same as in free outdoor running; a 
heart rate of >170/min for a 6-minute period, providing justification for the 
performance.  Spirometry exhalation occuring just 10 minutes after the exercise was 
related to practical problems in carrying out the study. 
Study design (I, II, III) included no prior sample size and power calculations. The 
sample size was relatively small increasing the probability of type II error (false 
negative finding). Analysis and interpretations of background factors within the groups 
particularly suffered from the small sample size. The sample size can, however, be 
judged to be sufficiently large, as significant differences were seen between the groups 
with regard to the main objectives of the study. In addition, odds ratios with confidence 
intervals reported for key outcomes allow the reader to quantify the power related to the 
results. These confidence intervals do justify the conclusions. 
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A limitation related to the study of parents of preterm and full-term children was 
the lack of data on background factors (e.g. smoking, socio-economic status, living area, 
pets); the questionnaire included only data on atopic symptoms and doctor-diagnosed 
atopic diseases in parents. Thus, the effect of possible confounding factors could not be 
taken into account in analysis by multivariate methods. 
FUTURE ASPECTS  
The results of differences in atopic findings and food antigen responses between 
children born preterm and those born full-term provide insight into the significance of 
early life in priming of immune responses, especially in development of tolerance. The 
role of immaturity in the process needs to be verified in future studies. These findings 
provide a framework for further research on early immunological mechanisms related to 
immaturity at birth.  
The epidemiological finding of a possible association between maternal atopy and 
maintenance of pregnancy offers new data on the effect of chronic immune disease on 
course of pregnancy. Many epidemiological and immunological studies are, however, 
required to verify this relationship and to clarify the underlying immunopathogenesis. 
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CONCLUSIONS 
This study was undertaken to evaluate the association between atopy and prematurity 
from two viewpoints. First, long-term effects of prematurity on the immune responses 
of the child were investigated in a group of 10-year-old children born severely preterm. 
A group of coeval children born at term served as controls. Second, the association 
between maternal atopy and premature birth was evaluated by comparing parents of 
VLBW children and parents of children with a birth weight above 3000 g. 
 
The main conclusions of the study are as follows: 
 
1. Significant prematurity at birth decreases the risk of later atopic sensitization. 
Immaturity of the immune system accompanied by a more permeable gut and 
qualitatively and quantitatively different early neonatal antigen exposure 
probably play a role in the maturation of immune responses.     
 
2. Children born severely preterm are, by 10 years of age, at risk of recurrent 
wheezing and impaired lung function, especially those who have had respiratory 
problems and intensive care treatment during the neonatal period. Atopy in this 
group is not associated with the cumulative incidence of wheezing but is a 
prognostic factor for wheezing at school age.  
 
3. Marked immaturity at birth has long-lasting consequences on food antigen-
related immune responses. Children born preterm produce at the age of 10 years 
markedly lower levels of antibodies to early-introduced food antigens, possibly 
reflecting increased susceptibility to develop tolerance.   
 
4. Maternal atopic immune balance may interact with and strengthen foetoplacental 
Th2 cell responses, thus supporting the maintenance of pregnancy.  
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